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ABSTRACT OF DISSERTATION
MIXTURE MODELING WITH APPLICATIONS IN ALZHEIMER’S DISEASE
This dissertation involves an application of mixture of regression models to 114 indi-
viduals who are cognitively intact (from the Alzheimer’s Disease and Neuroimaging
Initiative-ADNI, data). The correct number of components in the model were esti-
mated with the Singular BIC (SBIC), marking the first time it has been applied to
such a problem. The smallest true model in conjunction with the approximation of
SBIC was fixed at 1. The resulting posterior probabilities from the model were used
to estimate the probability of a person transitioning and risk plots were obtained
that could in principle be used by clinicians to identify patients at risk. This work
also proposed a model selection criterion for mixture of regression models with ap-
plication to the ADNI data. Finally simulation studies were conducted to compare
the performance of the novel model selection and existing criteria.
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Chapter 1 Introduction
1.1 Definition of Mixture Models and Examples
Let X1, ..., Xn denote a random sample of size n, where X j is a p-dimensional random
vector with probability density function f (x j) on Rp. Then we define a k component
finite mixture model:
f (x j) =
k∑
i=1
pi f (x j|θi) (1.1)
where the functions f (x j|θi) are called the component densities of the mixture and
the quantities p1, .., pk are the mixing proportions with 0 ≤ pi ≤ 1 and ∑ki=1 pi = 1.
The mixture model defined in this context assumes a known number k component(s).
However, in reality the number of components is inferred from the data and so are
the mixing proportions and the component- specific parameters. If we allow k to
increase with the sample size n, then the resulting model is called a mixture sieve
[19].
Example 1. Charnigo et. al.[27] modeled birthweight distribution of a population of
white singleton infants born to heavily smoking mothers in the United States. In this
study the number of components in the model was chosen with Flexible Information
Criterion (FLIC), a model selection criterion that imposes a penalty based on sample
size and data configuration. FLIC and Bayesian Information Criterion (BIC) chose a
4-component normal mixture as a good fit to the data. The resulting model structure
1
is given below and the plot corresponding to the model is shown in Figure 1 of
Charnigo et. al. (2010):
0.009 f (x, 872, 247)+0.231 f (x, 2890, 726)+0.707 f (x, 3165, 403)+0.054 f (x, 3821, 365),
where the two numbers in each component-specific density are estimated mean and
standard deviation. The first component of the model describes the distribution of
extremely low and very low birthweight (ELBW and VLBW) infants, component 2
describes mostly moderate low birthweight (MLBW) and normal birthweight (NBW)
infants with some VLBWs as well as high birthweight (HBW) cases. The third com-
ponent is similar to the mean component in a contaminated[31] and a 2-component
model[32]. The fourth component consists of NBW and HBW cases. The complexity
underlying the birthweight distribution as outlined cannot be adequately captured
with a single or perhaps fewer than four component Gaussian model. In the same
vein, fixing the number of components a priori may not yield reasonable results
because the appropriate complexity may vary across geographic and demographic
boundaries.
Example 2. Santago et. al. [26] applied two versions of finite mixture models
to automatically quantify single valued pixels of brain tissue types from Magnetic
Resonance Imaging (MRI). The brain data consist of four adjacent images. In the
first model, no partial volume effect was assumed; the errors were Gaussian with
homoscedastic variance and the mixing parameters summed to 1. The model con-
sists of three brain tissues; cerebrospinal fluid (CSF), white matter (WM) and gray
matter(GM) and is thus referred to as the three tissue model. The three tissue model
2
was stated as:
p(ν) =
∑
tT3 Pr[t]Pν|t(ν|t),T3 = {CS F,WM,GM},
∑
Pr[t] = 1
where ν is the pixel intensity and Pν|t is the component-specific density.
A second model called the six tissue model, assumed a partial volume effect.
However, the error terms were normally distributed. The six tissue model was defined
as:
p(ν) =
∑
tT6 Pr[t]Pν|t(ν|t),T6 = {CS F,WM,GM,CW,CG,GW},
∑
Pr[t] = 1
where CW, CG and GW represent combinations of the aforementioned three tissue
types. The resulting parameters in the models were estimated with tree annealing
algorithm which minimizes ||p(v)− h(v)||2 where h(ν) is the histogram of the data and
p(ν) is the model. Annealing algorithm is suitable for minimizing continuous func-
tions with only the known form of the function and not its derivatives. The quantity
of each brain material type was estimated with either parameter or Bayesian quan-
tification method. The Bayesian approach quantifies each tissue type by relying on
the normal model assumptions, the estimated mean and variance to optimize class
decision boundaries. On the other hand, quantifying tissues directly with estimated
parameters from the model was termed parameter quantification. The Bayesian ap-
proach was found to be more accurate and the three tissues model more consistent
in its fidelity to data as shown in Figure 5a in Santago et’ al. (1993).
3
1.2 Review of Applications
Mixture models have been used since the 19th century when they were applied by
Karl Pearson[13] in the analysis of crab morphometry [4]. Many novel applications
have been published in the fields of genetics, finance and engineering using mixture
models. Extensive discussions on the application of mixture models have been well
documented in Titterington et. al.[16] and Lindsay [17]. For instance a geneticist
might be interested in knowing if a disease population is homogeneous in situations
where a disease is caused in one group of individuals by one locus and in another
group of individuals by another locus.[4] Since the incipience of mixture models,
many methodological improvements have been proposed and justified. For exam-
ple, Mclachlan [3] used a bootstrap method to estimate the number of components
in normal mixture models. The bootstrap method was applied to a mixture based
on yields from seven barley types grown in 6-blocks. The purpose was to deter-
mine the number of mixture components when barley yields were clustered. The
method ultimately reduced the problem to choosing between two or three compo-
nent mixtures. At K=19 bootstrap replications the p-value obtained suggested that
the two-component model was more appropriate.
Chen and Chen[4] have shown that under the null hypothesis of homogeneity and
under some regularity conditions including a compact parameter space, the likelihood
ratio test statistic of a mixture model has an asymptotic distribution of (supθW
+(θ))2,
where W is a Gaussian process with mean 0 and variance 1. Other theoretical devel-
opments in the field of mixture models include the modification of the log likelihood
ratio test by Chen et al. [5] and the D-testing [6]. Chen et al.[5] modified the log like-
4
lihood of the finite mixture model by adding a penalty C log(4γ(1−γ)). They specified
two related motivations motivations for this modification; lack of identifiability prop-
erty in mixture models under the null hypothesis and the boundary issues regarding
the mixing proportion γ possibly being zero. Under the null hypothesis, the mixing
parameters are estimated as 1/2 leading to no effective penalty. Thus the penalty
only affects the alternative hypothesis model(heterogeneous model). The constant C
in the penalty is used to control the modification so that for a bounded kernel density,
one may choose C to be C = log(M) where M comes from the parameter space de-
fined as [−M,M]. Under the null hypothesis and regularity conditions, Chen et al[5]
obtained the asymptotic distribution of the modified likelihood ratio test (MLRT)
as 0.5χ20 + 0.5χ
2
1 where χ
2
0 denotes a degenerate distribution at zero. Furthermore,
a simulation study under the normal and the Poisson mixture models revealed that
when the Kullback-Leibler information is small, MLRT and the Neyman Scott test
[8] performed about the same and the method proposed by Mclachlan[3] performed
poorly. However for a large Kullback -Leibler information, the modified LRT was
preferable to the competing methods. Under the normal model assumption, Davies
[7] method was precise in terms of p-value estimates but less powerful in comparison
to the MLRT.
Charnigo et. al.[6] studied a new testing procedure for choosing the number
of components in finite mixture models. Their method relies on the Euclidean L2
distance between the competing models specified at the null and the alternative re-
spectively. Appealing features of the test include the emphasis it places on wider
differences between the density functions at the null and alternative hypotheses. In
5
addition it has a closed form expression with respect to the parameter estimates when
the mixture components are from standard parametric families. Another strength of
the test is its independence of the data given parameter estimates. As a result, test-
ing can be performed in the absence of the original data if the parameter estimates
are known.
Let X1 . . . Xn be a simple random from the mixture distribution
∑k
i=1 pi f (x|θi) where
pi ≥ 0, ∑ki=1 pi = 1, and { f (x|θ)|θΘ ⊂ L2} is a family of probability density function
associated with a scalar or vector parameter θ, then the D-test statistic can be defined
as
d(k, n) =
∫ [∑k
i=1 pˆi f (x|θˆi) − f (x|θˆ0)
]2
dx =
∫ [∑k
i=1 pˆi f (x|θˆi)
]2
dx
where pˆ0 = −1 and θˆ0 estimates the single parameter under the null hypothesis.The
corresponding closed form expressions for univariate and multivariate normal cases
are presented below:
d(k, n) =
∑k
i=0
∑k
j=0
pˆi pˆ j√
2pi(σˆ2i +σˆ
2
j )
exp
[
−12 (µˆi−µˆ j)
2
σˆ2i +σˆ
2
j
]
d(k, n) =
∑k
i=0
∑k
j=0
pˆi pˆ j
2dpid/2 exp
[
−12 ||µˆi − µˆ j||2
]
assuming an identity covariance matrix within each component in the latter for-
mula.
Let X1 . . . Xn be iid under null hypothesis H0 : X1 ∼ f (x|θ0), for θ0 an interior
point in the compact parameter space Θ. Then under the five regularity conditions
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assumed by Charnigo et. al. [6] the following convergence rates were obtained re-
garding maximum likelihood parameter estimation with k = 2 and p1 ≥ p2:
pˆ1(θˆ1 − θ0) + pˆ2(θˆ2 − θ0) = Op(n−1/2)
pˆ1(θˆ1 − θ0)2 + pˆ2(θˆ2 − θ0)2 = Op(n−1/2)
Note that assuming the wrong model (that is two component when there is really only
one) yields slower or no convergence: θˆ1 is n1/4-consistent while θˆ2 is not consistent.
To see this note that p1 ≥ p2,→ pˆ1 ≥ pˆ2 and we have that
Op(n−1/2) = pˆ1(θˆ1−θ0)2 + pˆ2(θˆ2−θ0)2 ≥ pˆ1(θˆ1−θ0)2 = Op(n−1/2)⇒ (θˆ1−θ0)2 = Op(n−1/2)
It follows that √
(θˆ1 − θ0)2 =
√
Op(n−1/2)⇒ |θˆ1 − θ0|= Op(n−1/4)
We also note that
Op(n−1/2) = pˆ1(θˆ1 − θ0)2 + pˆ2(θˆ2 − θ0)2 ≥ pˆ2(θˆ2 − θ0)2 = Op(n−1/2)
⇒ (θˆ2 − θ0)2 = Op(n−1/2) 1pˆ2
But since pˆ1 ≥ pˆ2, we get stuck because pˆ2 ≤ 1/2 ⇒ 1pˆ2 ≥ 2 with no lower bound.
Thus to find a bound for this expression we infer from what was established above
that (θˆ1 − θ0) = Op(n−1/4) and noting that pˆ1 ≤ 1, it follows that
pˆ1(θˆ1 − θ0) ≤ 1 × Op(n−1/4) = Op(n−1/4)
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It can be deduced that Xn = Op(n−1/2) ⇒ Xn = Op(n−1/4). Making use of the latter
relation we further deduce that
Op(n−1/2) = pˆ1(θˆ1 − θ0) + pˆ2(θˆ2 − θ0)
⇒ Op(n−1/4) = pˆ1(θˆ1 − θ0) + pˆ2(θˆ2 − θ0)
⇒ Op(n−1/4) − pˆ1(θˆ1 − θ0) = pˆ1(θˆ1 − θ0) + pˆ2(θˆ2 − θ0) − pˆ1(θˆ1 − θ0)
⇒ pˆ2(θˆ1 − θ0) = Op(n−1/4)
Using Taylor expansion, the convergence rate d(2, n) = Op(n−1) was then obtained.
The authors also showed that the testing procedure was consistent against a fixed
alternative.
The convergence rates above paved the way for properly rescaling critical values
for d(2, n) as elaborated below. Having that d(2, n) = Op(n−1) under the null and
dα;N(0,1) the corresponding critical value of d(2, n) for N(0, 1) then under the null
hypothesis and f (x|θ0) = N(0, 1),
P(d(2, n) ≥ dα;N(0,1)) ≈ α
and therefore conclude that dα;N(0,1) = O(n−1). If we assume more than was in
[6] and let nd(2, n) converge in distribution to F under the null hypothesis and
f (x|θ0) = N(0, 1), then we can have P(nd(2, n) ≥ F0.95) −→ 0.05, where F0.95 is the 95th
percentile of F. It follows that:
P(d(2, n) ≥ n−1F0.95) ≈ 0.05
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and
dα;N(0,1) ≈ n−1F0.95
For example, if dα;N(0,1) = 0.2 when n = 50, then it follows from the previous set up
that:
0.2 ≈ 50−1F0.95 ⇒ F0.95 ≈ 10
Now using the estimated critical value at n = 50, we can estimate dα;N(0,1) at another
n, say n = 100 as follows:
dα;N(0,1) ≈ n−1F0.95 ≈ 1100 × 10 = 0.1
Thus having estimated dα;N(0,1) at one n, the Op(n−1) convergence immediately esti-
mates dα;N(0,1) at another n.
Moreover, for any fixed n, let dα;N(µ0,σ2) and dα;exp(β0) denote the level α criti-
cal values of d(2, n) based on null distributions of N(µ0, σ2) and exp(β0). Then
dα;N(µ0,σ2) ≈ dα;N(0,1)/σ and dα;exp(β0) ≈ β0dα;exp(1) where the parameter spaces for the
assumed models are; [−M,M] and [M−1,M] for the normal and exponential distribu-
tions respectively. The D-test performed competitively with MLRT on two simulation
studies including mixture of normals on one hand and mixture of exponentials on
the other.
Gene differential expression testing presents new problems that have attracted
the attention of researchers in the field of mixture modeling. As new methodologies
are being uncovered to test for genes that are differentially expressed, it is worth
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noting that the student t-test can be and has been used to test for genes that are
differentially expressed. The t-test, although simple to implement, has the disadvan-
tage of increasing the false positive rate of the tests because of the number of genes
involved.Additional concerns about T testing are as follows:
1. With small number of subjects, within-group variances are poorly estimated
and results of T testing may be very sensitive to this [33] as well as any underlying
non-normality of expressions levels.
2. If the expression levels for different genes are correlated then the validity of
omnibus testing (i.e. analyzing numerous T test statistics together through homo-
geneity testing in mixture modeling) may be compromised [30].
3. Differential expression may manifest not only in a change of mean level, which
is measured by T testing, but also in a change of variability which is not assessed by
T testing [34].
Newton et. al [14] developed a semi-parametric hierarchical mixture model to
address the problem of detecting genes that are differentially expressed while ac-
counting for complexities of microarray data. They considered two types of prior
(mixing distribution) distributions on the mean gene specific expression: one para-
metric (gamma distribution) and the other non-parametric (defining the mean to
have a probability distribution on an equally spaced grid). The former prior actually
induced a parametric model intended as a comparator to the semi-parametric model
induced by the latter. The semi-parametric model performed similarly to the compet-
ing parametric model when applied to data from the Gene-logic spike-in experiment.
The poorest performance in the comparison was recorded by the gene-specific T test.
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When the models were tested for robustness in a case study using a data leave-out
approach, the semi-parametric model identified 80% of down regulated genes com-
pared to 61% by the parametric method. The method proposed by Newton et.
al. was limited to a simple two-group comparison and ignores dependencies among
genes (conditional on gene-specific parameters). Also the non parametric prior can
slow down the performance of the EM or other optimization algorithms.
Besides the semi parametric model approach in the aforementioned discussion,
Bayesian models amongst others have also been used to obtain useful gene expres-
sion information in recent years. For example Zhou et. al [19] used Bayesian mixture
models to partition gene expression data and Alexandridis et. al. [21] developed
a multi-type classification method for gene selection and tissue sample separation.
In particular, Newton et. al. [28] developed EBarrays in R to compute dual char-
acter posterior probabilities for detecting patterns of genes and condition-specific
expected values. This method was believed to capture relevant sources of variations
in a high-dimensional expression profile and thus considered superior to some existing
methods such as the paired sample T test. EBarray also require fewer replications
of microarray data and does not require permutation. The undergirded assumptions
of EBarray are as follows:
a) Parametric observations component (log-normal or gamma)
b) Parametric mean component (conjugate to observation component)
c) Constant coefficient of variation
d) Only marginal information (rather than among-gene dependence) is relevant
The log-normal-normal hierarchical (LNN) model in EBarray package when ap-
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plied to mammary epithelial tissue from a rat model of breast cancer , identified
92.7% of the genes as equivalently expressed. EBarray models are however limited
by the assumptions underlying its operations. For instance it will under perform
if the constant variance assumption is violated or if the data deviate from the log-
normal-normal assumption. To increase the flexibility of the model, Newton et. al.
suggested using a nonparametric mean component approach. It is worth noting that
Speed [29] used a similar approach as Newton et. al.[28] but did not assume constant
variance of gene-specific expressions. As a result, Speed’s flexible model may provide
yet another avenue to model varying mixture components.
Omnibus tests [30] are also extensions of mixture models designed to overcome
difficulties in simultaneous testing of differentially expressed genes. Suppose we de-
cide to test for gene differential using t-test and adjust for multiplicity using the
Scheffe, Kolmogorov and Tukey. Such a test will have low power for detecting differ-
ential expression due to the conservative nature of the pairwise comparison methods.
Omnibus tests combines the D-test [27] and modified likelihood ratio test [5] to
determine whether p-values obtained from models used in testing differentially ex-
pressed genes come from uniform or beta contaminated distributions (uniform and
beta mixture). If the p − value ∼ Uni f (0, 1) then the batch of genes considered are
not differentially expressed otherwise they are considered to be coming from a Beta
contaminated distribution. The Beta contaminated model for p-values is defined as
follows:
Let P1, Pn be the random p-values from n hypothesis tests. For i = 1, .., n define Zi = 1
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if a gene is differentially expressed and 0 otherwise. The conditional distribution are
given as (Pi|Zi = 0) = uni f orm(0, 1) = Beta(1, 1) and (Pi|Zi = 1) = Beta(α, β). Thus the
marginal distribution of Pi for all i = 1, , n is P(Pi|Zi) = (1 − pi)Beta(1, 1) + piBeta(α, β)
for 0 ≤ pi ≤ 1, α > 0 and β > 0. The corresponding posterior of p˜i = P(Zi =
1|Pi, α, β) = pi f (pi;α,β)1−pi+pi f (pi;α,β) , where p˜i > T , for some cut off T, suggests that the ith gene
is differentially expressed.
The omnibus testing is applauded for the following strengths:
1) Ability to efficiently dispose of a batch of genes without alterations and thus in-
creasing the power of the test.
2) Estimated parameters from the model can provide a frame of reference for multi-
ple comparisons of the remaining batch.
3) Robustness in the sense that p-values from different distributions can be detected
assuming the p-value distribution is uniform under the null hypothesis and Beta con-
taminated otherwise.
In addition, omnibus testing can reject the uniform(0,1) model even in the face of
choosing α∗ = 0 and α∗∗ = 1 and it uses parameter estimates to determine the number
of true positive, false positive and posterior differential expression probabilities to im-
prove gene differential detection. In light of these strengths however, this testing
procedure assumes independence of the p-values that may not be correct even though
incorporating a covariance matrix of hundreds if not thousands of p-values may be
challenging if not impossible and modeling p-values rather than the full data makes
it impossible to recover information lost[28]. The assumption of a two-component
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mixture is overly simplified but agrees with bootstrap studies [3] that two mixture
assumption is appropriate in finite mixture problems. Furthermore, treating some
parameters in the Beta distribution as known a priori may introduce biases into the
testing procedure. These limitations call for an improvement to account for the iden-
tified problems.
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1.3 Review of Mixture Model Applications to Alzheimer’s Disease
Alzheimer’s disease (AD) is another area where mixture models have been applied for
diagnostic purposes. The Centers for Disease Control and Prevention defines AD as
a ’progressive disease beginning with mild memory loss possibly leading to loss of the
ability to carry on conversation and respond to the environment’. Three core criteria
for identifying the predementia phase of AD have been proposed by a working group
under the direction of the National Institute on Aging and the Alzheimer’s Associ-
ation. These include clinically based criteria for clinicians and healthcare providers,
biomarker (cerebrospinal fluid measures) and brain imaging for research purposes
and a combination of the clinical and biomarker evidence [25]. The prevalence of
AD in the United States in 2013 was 5 million projected to be 14 million in 2050
[24]. Identified as the most common form of dementia, AD incidence is between 60
and 80 percent of all dementia cases [24]. In 2010, an estimated 600,000 (32% of all
older adults death) adults 65 years and older with AD died in the United States. It
is projected that mortality rates due to AD could top 43% of all older adults death
by 2050. [22].
Presently, De Meyer et. al [9] are among few researchers who have used nor-
mal mixture components to separate patients with AD from those without using
biomarkers. Using a mixture model framework, De Meyer et. al. classified cogni-
tively normal elderly people into one of three categories; Alzheimer, mild cognitive
impairment (MCI) and cognitively normal (NC) using biomarkers. Many studies
have reported on the reliability of using biomarkers for detecting AD in its early
stages. For instance Hampel et al.[10] compared the AD predictive potentials of
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many existing biomarkers such as cererospinal fluid (CSF) tau protein (p − tau199),
threonine 231 (p− tau231), threonine 231 and serine 235 (p− tau231−235) threonine 181
(p− tau181), and serine 396 and serine 404 (p− tau396/404). They identified CSF total-
tau (t-tau) and CSF beta-amyloid1-42 to have reasonable sensitivity and specificity
rates for differentiating early and incipient AD groups from other age-associated dis-
ease such as Lewy body disease and some secondary dementia.
The procedure adapted by De Meyer et. al.[9] consists of three steps. First they
applied mixture models to a data set from the US Alzheimer’s Disease Neuroimaging
Initiative (US ADNI) using a single biomarker (CSF Abeta1-42) to differentiate be-
tween Alzheimer’s and none Alzheimer’s cases. This resulted in a sensitivity of 91%
and specificity of 62% when a cutoff value of 188pg/ml was used. A different decision
criterion that balances the two arms of the ROC curve yields a comparable rate for
the sensitivity (74%) and specificity(75%). Overall, 25.2% of the observations were
misclassified.
In the second and third steps, De Meyer and colleagues extended their method to
include the biomarkers CSF p− tau188p and or CSF tau. With an Akaike information
Criterion (AIC) difference of 26 between the two competing models, the Abeta1-42
and CSF tau181p (AIC= 4137) model was selected over the Abeta1-42 and CSF tau
model (AIC = 4163). The selected model was validated with two independent data
sets; an autopsy data set and a ADNI data set. The model detected 90% of AD sig-
nature in the AD group, 70% in the MCI group and 36% in the cognitively normal
group of the ADNI data set. Out of 68 autopsy confirmed AD cases, 64 cases were
correctly (94% sensitivity) classified as AD. The model also identified correctly all
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patients on track to AD (100% sensitivity) when patients with MCI conditions were
followed for 5 years.
The model’s performance hinges on the functions of the two biomarkers; CSF
Abeta1-42 as an initial biomarker and CSF p tau181p as a subsequent stage biomarker
associated with progression towards dementia. These intrinsic characteristics of the
selected biomarkers are not new as documented in the literature by many authors
including Montine [11], Albert et. al. [2], Stomrud et. al.[15] and Gustafson et. al.
[12].
De Meyer and colleagues noted that AD signatures were present in 39% cog-
nitively normal persons for the single biomarker model and 36% for the combined
biomarker model. They concluded that these observations were consistent with neu-
ropathological studies that healthy elderly individuals tend to have amyloid contain-
ing plaques and tau containing neurofibrillary tangles in their brains[9]. Thus their
method was consistent with expected AD diagnosis and thus serve as a platform
upon which future models may be developed.
De Meyer and colleagues’ work breaks ground for further expansions in this area.
Notably addition of Apolipoprotein (APO4); the most robust genetic risk factor for
sporadic AD known to be related to AD, MCI and NC [35] in the analysis may lead
to improved results. We applaud the authors for their ground breaking application
of mixture models to addressing AD related problems however they did not address
all the potential stages of MCI as published by ADNI. Being able to detect candi-
dates with early MCI (eMCI) may prove vital in delaying the development of AD
using available therapeutic procedures. Although a hypothesis was not tested by the
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authors, identifiability problems which are inherently associated with mixture mod-
els were not addressed by the authors. The use of AIC as the only model selection
criteria raises concerns as it has been shown that AIC favors small sample size and
more mixture components [27]. Thus the Flexible Information Criteria may be more
appropriate in this case as the penalty involved considers the configuration of the
data points in addition to the sample size [27]. Finally, the wide variations in the
concentrations between different aliquots of Abeta1-42 [36] can significantly alter the
conclusions drawn from the two models. Perhaps following the guidelines in [36] may
help stabilize the variations in the concentrations of the analyte and thus improve
the outcome from the models.
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1.4 Review of Existing Model Selection Criteria and Mixture of Regres-
sion
Many model selection criteria span the field of mixture models. Popular amongst
these selection criteria are MLRT[5], D-test[6],FLIC[27], BIC and AIC.We should
observe that MLRT and D-test are hypothesis testing procedures compared to BIC,
AIC and FLIC which are information theoretic criteria. However,the hypothesis
test procedures may be used for model selection by determining the model complex-
ity (or number of mixture components in the underlying population). Drton and
Plummer(2016)[44] developed the singular Bayesian Information Criterion (sBIC)
to address model selection problems arising from singular models (models whose
Fisher information matrix is singular). The authors noted that sBIC differs from
BIC in that although they both have Bayesian flavors, the regularity conditions un-
derpinning the derivation of BIC are not satisfied by singular models. The authors
proposed: sBIC(Mi) = log L′(Mi) where Mi is a finite set of candidate models and
{L′(Mi) : i ∈ I} is the unique solution to the equations ∑ j≤i [L′(Mi) − L′i j]L′(M j) = 0,
i ∈ I, that has all positive entries with L′i j = P(Yn|pˆi,Mi)n−λi j(log n)mi j−1 where λi j is the
learning coefficient and mi j is the multiplicity of λi j. Compared to BIC, the authors
demonstrated that sBIC can achieves better frequentist model selection behavior,
and allows more posterior mass to be assigned to larger models. When the models to
be selected are regular, sBIC selects the same model as BIC; sBIC however does not
rely on Monte-Carlo computation but rather on the information about the learning
coefficient. For moderate number of models, sBIC and BIC have comparable compu-
tational burden. However there is a need for future work to address computational
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burdens associated with the use of sBIC when larger models are involved.
Viele and Tong (2002)[46] proposed modeling with mixtures of linear regressions
where the outcome of interest was modeled conditional on a set of covariates and
the prior was implicitly data dependent. The key additions to the mixture mod-
els paradigm from this procedure include the ability to adjust for covariates, ac-
count for masked outliers and also ensure consistency of the posterior distribution
using bracketing entropy. The likelihood of interest was defined as g(yi|xi1, ..., xip) =∑k
j=1 p jN
(∑P
p=1 xipβ jp, σ
2
j
)
(yi) where β jpεR for j = 1, ..., k, and p = 1, ..., P are re-
gression coefficients, σ2jεR
+ are the regression variances and (p1, ..., pk)εS k are the
relative probabilities of the k components with S k being a dimensional simplex
s = (s1, ..., sk) : s j > 0,
∑
s j = 1. Their approach has a Bayesian flavor in that they
placed priors on the mixing components, regression coefficients and regression vari-
ances ( Dirichlet, normal and Gamma respectively [refer to section 2 page 317 de-
tails]). The posterior modes in the model were estimated with an EM algorithm and
Gibbs sampling was used to sample from the identified modes.
Dai and Charnigo (2010) studied omnibus tests using Z or T statistics from
multiple differential expression testing of genes assumed to arise from an underly-
ing contaminated normal mixture model(CN). Prior to this study the authors de-
veloped the contaminated beta model(CB) for analyzing p-values arising from dif-
ferential expression tests. The CN model with the corresponding hypothesis for
the omnibus test were proposed as (1 − γ)N(0, σ2) + γN(µ, σ2) and H0 : γµ ver-
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sus H1 : γµ , 0 and the the penalized maximum modified likelihood was given as
l∗n(γ, µ, σ
2) =
∑n
i=1 log[(1 − γ) f (Zi; 0, σ2) + γ f (Ai; µ, σ2)] +C log[4γ(1 − γ)] where Zi is
the resulting Z statistic from the ith test, γε[0, 1] is the proportion of genes in the
batch that are deferentially expressed, µ and σ2 are the mean and variance of Zi given
differential expression of the ith gene respectively. The hypothesis test was carried
out with modified likelihood ratio test and D-test. Of note, the parameter estimates
from the maximum modified log likelihood(MMLE) were utilized in the calculation
of the D-test; an advantage of the D-test is that one only need to have the parameter
estimates to use the test. In an empirical study to compare the performance of the
new model (CN) to the old (CB), the authors noted that CN yields a more powerful
test than CB when there’s lack of symmetry between the over and under expressed
gene batches; the ratio of |µ| to σ in CN is not too large; and when two sided test
is of interest. To choose between the two models (CN or CB) one can apply a BIC
type criterion on the estimated MMLEs from the two models.
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Chapter 2 An Application of A Bivariate Normal Mixture Model
Introduction
Our research in this and subsequent chapters differs in many respects from exist-
ing analyses that used mixture modeling to analyze AD data[9]. Notable differences
include: 1) we consider all three biomarkers simultaneously instead of investigating
them pairwise. That is considering the n × 3 outcome matrix Y := (Y1i,Y2i,Y3i),
i = 1, 2, 3, ..., n,where n is the number of individuals, we derive the n×2 response ma-
trix Y∗ := (Y∗1i,Y
∗
2i), i = 1, 2, 3, ..., n corresponding to ratios of the original biomarkers
where Y∗1i =
Y1i
Y3i
and Y∗2i =
Y2i
Y3i
, i = 1, 2, 3, ..., n ; 2) we prioritize placing people in groups
based on biomarker data collected while they are still healthy and utilize an estab-
lished mixture method to predict their future status, rather than placing people in
groups based on biomarker data collected after they exhibit cognitive decline. At
that point it will be relatively easier to separate groups, but such focus may lack
prognostic relevance to those who are cognitively normal today but can potentially
develop AD in the future; 3) since AIC is known to overestimate the number of com-
ponents or groups [27] other statistical criteria such as singular Bayesian Information
Criterion (sBIC) are used in addition to AIC to choose the number of groups or com-
ponents; and, 4) more sophisticated statistical modeling is considered, to account for
other covariates such as APOE4, age, gender, race, mini mental state exam score at
baseline and level of education.
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2.1 Motivation and Objectives
As we have already alluded to in our introductory section of this dissertation, AD
is progressive in nature which means it worsens over time starting with a mild loss
in cognition and later developing into dementia where the affected persons lose their
ability to interact with or respond to their environment. Every 67 seconds, on aver-
age, someone living in the United States develops AD. One in three seniors dies with
AD or another form of dementia [38].
In addition to the burden of this disease to families, the estimated related care
cost paid by Medicare was about $11 billion in 2010 [52]. However, very little re-
search in the literature has relied on mixture modeling to address the identifying
candidates who are at high risk of transitioning from normal cognition at baseline.
As far as we know, only one article ([9]) used mixture modeling to diagnose AD. This
chapter differs from [9] and adds to the literature in four major ways as embodied in
the objectives and explained here:
1. We apply mixture models to individuals who are cognitively normal as opposed
to [9] where the participants were a combination of cognitively normal, mildly
cognitively impaired and AD.
2. we use derived variables such as tau/ abeta and ptau/abeta as in [48-51] in
which the authors showed that tau/abeta was a good predictor of future de-
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cline in cognition.
3. We use sBIC in addition to the traditional model selection criteria (AIC and
BIC) to select the number of components contrary to using only AIC as in [9].
We note that AIC may overestimate (too liberal) the model complexity and
BIC may underestimate (too conservative) it. Hence AIC or BIC alone may
be inadequate. However unlike AIC, sBIC operates on a Bayesian principle
and in general neither overestimates or underestimates the model complexity
as explained in [44]. If AIC and BIC disagree on the model complexity, sBIC
may serve as a tie breaker.
4. We adjust for other well established covariates associated with cognitive decline
whereas [9] did not.
Specifically in this chapter we use mixture modeling to achieve the following goals:
Objective 1:
To statistically determine the degree of heterogeneity within the population from
which the data were drawn.This population constitutes all people who could po-
tentially volunteer to participate in the ADNI study and are willing to undergo
lumbar puncturing to test whether or not AD proteins are present in the spinal
fluid. Objective one entails fitting various bivariate mixture models with differing
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number of groups (components) and estimating the complexity of the smallest true
model. Suppose once again that Y := (Y1i,Y2i,Y3i), i = 1, 2, 3, ..., n we define the
ratio of biomarkers as Y∗ := (Y∗1i,Y
∗
2i), i = 1, 2, 3, ..., n,where Y
∗
1i =
Y1i
Y3i
and Y∗2i =
Y2i
Y3i
,
i = 1, 2, 3, ..., n represent the two ratios formed from the three biomarkers. Suppose
moreover, that the response for a particular individual arises from the joint bivariate
normal mixture distribution whose density is g(y) =
∑m
k=1 θkN(µk, σ
2
k)(y) where θk is
the mixing parameter for component k, m is the unknown number of components
we wish to estimate, µk is a two vector of component means and σ
2
k is a 2 × 2 co-
variance matrix for component k. So a two component mixture will take the form
θ1N(µ1, σ21) + θ2N(µ2, σ
2
2) where θ2 = 1 − θ1 since in general θ1 + θ2 + ... + θm = 1. We
use various information-theoretic criteria (e.g., AIC, BIC and singular BIC[44]) to
decide how many groups are suggested by the data.
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Objective 2:
To investigate whether mixture components from objective 1 predict future dis-
ease status (i.e. cognitively normal, mild cognitive impairment, Alzheimer’s Disease)
and thereby estimate the hazard of future disease within each group. Suppose that T
is a continuous random variable denoting the length of time(months) to event(AD)
then T can be censored or uncensored depending on whether or not the event of
interest was observed. The corresponding hazard rate can be generally defined as
λ(t) = limδ→0
P(t≤T<t+δ|T≥t)
δ
=
f (t)
1−F(t) where F and f are the cumulative and density
functions of T. Furthermore, the hazard rate is related to covariates through the
functional form λ(t|X) = λ0(t) exp{Xβ} where X = (X1, X2, ...XN)T for some finite num-
ber N of covariates, consisting in our case, of estimated probabilities from the mixture
model, age, race, APOE4 and or level of education. We define covariates to permit
future adjustments.
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2.2 Methodologies, Cognitive Assessment and Review of Related Con-
cepts
Participant Characteristics
The data set used in this study is a subset of the original data from the ADNI
study. ADNI was launched in 2003 and was spearheaded by Dr. Michael Weiner with
the goal of testing magnetic resonance imaging (MRI), biomarkers and other modal-
ities to measure progression of and to mild cognitive impairment and Alzheimer’s
disease. The ADNI project has three phases: ADNI 1, ADNI GO and ADNI 2.
The first phase commenced in 2003 with a participant pool of 200 normal control,
400 with MCI and 200 with mild AD. The first phase ended in 2010 and the second
phase began (2009) prior to phasing out the first. ADNI GO is made up of 200 newly
recruited participants with early MCI (EMCI) and 500 normal controls and MCI in-
herited from ADNI 1, making up a total of 700 participants. This phase ended in
early 2011. The third phase ADNI 2 started in early 2011 slightly overlapping the
second phase. The participants included 150 new normal controls, 150 new EMCI,
150 new late MCI (LMCI) and 200 new mild AD. Approximately 450 to 500 partic-
ipants with normal cognition and MCI came from ADNI 1 and approximately 200
participants with EMCI are included from ADNI GO[47]. The de-identified data are
publicly available at adni.loni.usc.edu and can be obtained by completing a registra-
tion process.
From Table 2.1, 779(44.9%) of the participants are females and 956(55.1%) are
males. There are 3(0.17%) American Indians, 29(1.67%) Asians, 77(4.44%) Blacks,
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2(0.12%) Hawaiians, 21(1.21%) unknown and 1603(92.39%) Whites. Non-Hispanic/
Latinos make up 1666(96.2%) of the sample while Hispanic or Latino make up
58(3.34%). The minimum age at enrollment is 48.1 years and the maximum is 91.4
years old.
Our interest lies with the n = 114 subjects with known ages and biomarker levels
classified by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) as cognitively
normal at their baseline visits based on a mini mental state exam (MMSE) score
between 24 and 30, a clinical dementia rating sum of boxes (CRDSB) score of zero
and the absence of depression, MCI or dementia [9]. We arrived at 114 participants
by removing all duplicates with nodupkey with SAS procedures. The demographics
of the participants in this subsample are shown in Table 2.2 and Figure 2.1 illustrates
the distribution of the biomarkers Abeta142, Ptau181p and Tau. The distribution
of Abeta142 appears to be bimodal: one mode at lower Abeta142 values (less than
200) and the other mode at higher Abeta values(above 200). The Tau and Ptau
distributions are arguably bimodal and most of the observations accumulate at the
lower values. The distributions are skewed to the right. The derived biomarker
measures are shown in Figure 2.2. The derivations are obtained by taking a ratio
of Tau and Ptau with respect to Abeta142. Both distributions are also negotiably
multimodal and skewed to the right akin to their counterparts in Figure 2.1. In
addition the distributions appear to suggest three distinct groups: one large group
on the extreme left another smaller group in the middle and a third on the extreme
right which consists of few observations especially of Ptau181P/Abeta142. The three
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groups apparent in the distributions of the derived variables are more visible to the
untrained eye than the original variables (using the same breaks=20 in R package) in
figure 2.1, which could provide a strong hint that the estimated number of mixture
components mˆ in this chapter’s formal data analysis might be three.
The Institutional Review Board (IRB) at the University Of Kentucky approved
an exemption for the use of this data set on conditions including: 1) that the data
will be stored on a jump drive accessible to the two specific persons only and 2) that
the IRB will be informed of any substantial future changes to the study described in
the application.
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Figure 2.1: Original Biomarkers
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Figure 2.2: Derived Biomarker Histogram
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Cognitive Assessment
To ascertain that the participants in our data are indeed cognitively normal at
baseline, we examine a cross tabulation of the clinical dementia rating sum of boxes
(CDRSB) and MMSE baseline to assess the degree of agreement between the two
scores. Participants’ scores at or below 24 on the MMSE scale or at 0.5 or higher on
the CDRSB scale will counter the claim of normal cognition according to [39] and
[40]. From Table 2.5 eight (8) participants in our data set who scored at and above 27
on the MMSE scale at baseline present a score at or greater than 0.5 on the CDRSB
scale. These participants’ CDRSB and MMSE baseline scores are compared with
the Alzheimer’s Disease Assessment Score (ADAS11) and the Rey’s Verbal Auditory
Learning Test percent forgetting (RAVLT) score.
Two of the eight with MMSE baseline scores of 27 and 30 respectively also have
the same score of 6.67 for ADAS11 and their RAVLT forgetting scores are respectively
36% and 7.7%. Of those who scored 0.5 on CDRSB scale, two scored approximately
31% and 33% on the RAVLT forgetting scale with a corresponding 5.0 and 3.33 on
the ADAS11 scale. The participant who scored 2.5 on the CDRSB scale also scored
71% on the RAVLT forgetting scale and 7 on ADAS11 scale with 30 on the MMSE
baseline scale. One participant with a score of 1 on the CDRSB scale, 11 on ADAS11
scale, and 30 on MMSE baseline scale also scored 100% on RAVLT .
Based on these findings the participants that scored 0.5 and above on the CDRSB
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scale will be included and excluded in two versions of the model fitting process to
see if they influence our results. If dramatic changes such as a significant decrease
or increase in the c-statistic, log rank test p-value, huge swings in the standard error
estimates or covariates’ p-values occur due to the absence of the eight participants’
information in the modeling, then the output from both sets of the results will be
presented: one with the participants excluded and the other with the participants
included. If however there’s no such dramatic changes from the inclusion or exclusion
of the information from the eight participants then we shall present the output with
information on all eight participants.
Statistical Modeling
As introduced in chapter 1 and re-emphasized earlier in this chapter a variety of
mixture models will be fitted throughout this dissertation. In chapter 2 we fit the bi-
variate normal mixture model (BNM) without covariates using the mixtools package
in R[42] and write and R code the sBIC function for model selection. The responses
are collected in an n × 2 matrix whose columns correspond to TAU/ABETA142 and
PTAU181/ABETA where n = 114. The number of mixture components representa-
tive of the underlying heterogeneity in the data will also be selected using AIC, BIC
and sBIC.
The aforementioned objective 2 is to predict the future cognition status of cog-
nitively normal individuals into one of three groups: normal cognition (CN), mildly
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impaired cognition (MCI) and Alzheimer’s (AD).
Bayes method will be implemented to determine the respective (posterior) prob-
ability of individuals belonging to a given group given their biomarker information.
We will classify individuals into one of two or three groups depending on the chosen
number of mixture components. The characteristics of members in each component
will be assessed based on current knowledge of the biomarker literature and visual
representation; and the groups will be labeled as either (projected) cognitively normal
(CN) or MCI/AD for the two component mixtures or (projected) CN, MCI and AD
for the three component mixture. A high risk group will have higher scores overall
on the TAU/ABETA and PTAU181/ABETA142 scales compared to a low risk group.
A multivariate Cox regression model for survival time of conversion from CN to
MCI or AD will be used to assess the predictive utility of the model as expressed by
the concordance (c ) statistic. The logrank p-value associated with the hard classifica-
tion will be used to test whether the group of survival time are statistically different.
The raw (soft classified) and hard classified posterior probabilities of belonging to a
component will be included in the Cox model such that a two component mixture
model will yield one vector of posterior probabilities that represents the probability
of belonging to the higher risk group. In this case, the group whose probability vector
was not included in the model will be the baseline or referent risk group. For a three
component mixture model we will have two probability vectors included in the Cox
model: one vector for each of the two higher risk groups, and the third probability
34
vector not included in the Cox model will represent the baseline/referent risk group.
Review of related concepts
The singular BIC model selection criterion introduced in chapter one will be
used in chapter two. A brief overview of the underlying principles is in order. The
sBIC is approximated as exp (sBIC(Mi)) ≈ P(Yn|pˆi,Mi)n−λi j(log n)mi j−1 where λi j is the
learning coefficient and mi j is the multiplicity of λi j[44]. In this chapter we assume
a lowerbound for mi j to be 1 consistent with [44] and deduce the upperbound for λi j
as follows. Suppose the bivariate response of interest is Y∗ as before and define the
parameters
Σ =
 σ
2
1 σ1,2
σ2,1 σ
2
2

µ =
 β1β2

and
Θ =

θ1
...
...
θm

; where m is the number of components ( or model complexity), Θ is a vector of mix-
ing coefficients, Σ is the component specific covariance matrix and µ the component
specific vector of means.
35
Then to obtain an upperbound for the learning coefficient λi, j we either fix the
last i− j entries of the mixing coefficient Θ or prior distribution for group membership
(as regards to Bayesian methods) and estimate the number of free parameters (in
this case component specific Σ and µ) or fix the parameters Σ and µ in the last i − j
components and allow Θ to vary.The primary goal here is to make the free parame-
ters for the model estimable by overcoming the identifiability issues associated with
mixture models.
Let us proceed by fixing Θ. Furthermore let’s assume that i and j are respectively
the indices two true models as in [44] with i > j and j is the index of the smallest
true model. Then the number of free parameters for this model can be generated as
follows:
1. For j = 1 versus i = 2 we have N(µ1,Σ1) + 0N(µ2,Σ2) which yields 10 free pa-
rameters.
2. For j = 2 versus i = 3 we have θ1N(µ1,Σ1) + (1 − θ1)N(µ2,Σ2) + 0N(µ3,Σ3) thus
giving rise to 16 free parameters.
3. For j = 1 versus i = 3 we have N(µ1,Σ1) + 0N(µ2,Σ2) + 0N(µ3,Σ3) thus giving
rise to 15 free parameters.
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The number of free parameters generated form a pattern that can be expressed
as 5i + j − 1. Accordingly we can bound the learning coefficient from above by
λi, j ≤ 12 [5i + j − 1].
Notice that if we fix Σ and µ in the last i − j component and allow Θ to vary, we
get an upperbound of the form λi, j ≤ 12 [i + 5 j − 1] (see [44] for similar derivations
regarding the upper bound for the learning coefficient). Of note the smallest true
model is fixed at j = 1 in subsequent work throughout this dissertation.
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2.3 Results and Discussion
The BNM model reveals a three-component mixture underlying the distribution of
the biomarker ratios as the correct model based on sBIC estimated values and as
indicated in Table 2.3 and Figure 2.3 respectively. From Table 2.3 we notice that
the AIC and sBIC are in agreement as opposed to the BIC. However when we obtain
the probability of the correct model based on the biomarker information using the
sBIC estimated values we notice that in fact the three component (with estimated
probability of being correct = 1) model is narrowly preferred to a four component
model (with estimated probability of being correct ≈ 0.9999). The estimated prob-
abilities in each rectangle in the three histograms of Figure 2.3 are indicative of
the individuals who apparently (rectangle near 1) do or do not (rectangle near 0)
belong to the component under consideration given their biomarker information or
who are not conclusively classified (rectangles between the two main peaks). That
is individuals with P(X = x|Y∗) ≈ 1 almost surely belong to the component x and
for those with P(X = x|Y∗) ≈ 0 almost surely do not belong to the component in
question, where X and Y∗ are the latent grouping variable and the biomarker ratios
respectively. Those with 0  P(X = x|Y∗)  1 are comparatively fewer in number
and have posterior probabilities identified between the two extreme rectangles and
are illustrative of uncertainty about component membership.
Component three shows that about 10% of individuals in the sample belong to
the component and about 90% do not. Components one and two on the other hand
have comparable numbers of participants who belong with probability near 1 and
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who do not with probability near zero. Figure 2.3 also suggests an overlap between
components one and two due to the greater numbers of uncertain memberships in
these two components. As a result component three is well separated from compo-
nents one and two, an observation that is also well captured in Figure 2.4. In Figure
2.4 members of component one (as judged by hard classification) have comparatively
the lowest risk ratios compared to components two and three. It also shows that two
members of component three may be outliers (with respect to their rtaubeta values)
in the sense that even though they have comparatively larger rptaubeta values their
rtaubeta values are within the range of components one and two. The observed out-
lier may have been missed if only one biomarker has been used in the study.
The risk comparison plots in Figure 2.5 also shows the least in cognitive decline
risk for members in component one (as judged by hard classification) compared to
their counterparts in components two and three. Component three shows the steepest
decline in survival compared to component two after the 50th month of follow-up. We
also see the sharpest decline in survival for component three members at the 96th
follow-up month whereas the sharpest cognitive decline for component two takes
place around the 50th month of follow-up.
We compare the densities in each component using two dimensional contour plots
displayed in Figure 2.6. The plot indicates that the densities in components one and
two have the steepest contours compared to component three; an indication of lesser
variability amongst members of these components (not a surprise as suggested by
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Figure 2.4). An interesting observation from Figure 2.6 relates to the directions of
the contour plots; components one and two exhibit similar directions whereas com-
ponent three exhibits a direction opposite to that of components one and two. Thus
in components one and two, the biomarker ratios are positively correlated whereas
in component three they are negatively correlated.
Two Cox model outputs are generated from the hard classification and raw (for
soft classification) estimated Bayes probabilities of belonging to a component given
one’s biomarker information. Each of the two Cox model outputs are adjusted for
covariates in the data set and membership in component one is used as the reference
as it presumably has the least risk.
In the hard classification output in Table 2.4, the posterior probability related to
component two is significant at α = 0.001 adjusting for the posterior probability re-
lated to component three. The reverse is also true as seen in Table 2.4. A unit increase
in component one posterior probabilities increases the estimated hazard of developing
AD by three (HR = 3.02, 95%CI = (1.36, 6.68)) fold compared to posterior probabili-
ties in component 2 whereas a 10% change in the posterior probabilities in component
three increases ones estimated hazard by over 5 (HR = 5.35, 95%CI = (1.89, 15.15))
fold. In other words,a person who transitions from component two to component one
will experience an increase in hazard rate of about 3.02 whereas a transition from
component two to component three will increase the hazard rate by 5.35. The con-
cordance statistic is 63.3%. Adjusting for covariates led to an increase in the overall
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concordance. We also observe that immediate RAVLT (Reys Auditory Verbal Learn-
ing Test) offers a significant (HR = 0.94, 95%CI = (0.90, 0.98)) protection for AD
accounting for the other covariates in the model. Race was however not a significant
predictor of the time to transition, however, including race in the adjusted model
improved the c-statistic (from 0.73 to 0.76), hence we included race in the model.
Education, gender, MMSE, and age were all included in the adjusted Cox model and
eliminated by backward elimination method. The absence of latter covariates did not
influence the c-statistic. The output from the soft classification model indicates that
in addition to the posterior probabilities being significant predictors of the time to
transition, race (HR = 0.312, 95%CI = (0.11, 0.87)) is now a statistically significant
predictor of time to transition although it wasn’t in the hard classification model.
The soft classification model has a comparatively modest gain in c-statistic and a
modest increase in standard errors which consequently led to wider confidence inter-
vals. The global proportional hazard tests were not significant in both the hard and
soft classification cases.
The BNM model output without the eight participants as mentioned above in
the cognitive assessment section is shown in Table 2.7. The output with all partic-
ipants included in the modeling process was displayed in Table 2.4. In Table 2.4
the estimated hazard rate and standard error for component three posterior proba-
bilities is 5.35(S E = 0.53) which differs narrowly from the estimated hazard rate of
4.76(S E = 0.56) in Table 2.7. These are the most notable difference between the two
mixture models. Apart from these differences, the other estimators are comparable
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although the soft classification model in Table 2.7 seem to gain in the concordance
statistic albeit with larger confidence intervals. Since the two outputs are similar we
will henceforth discuss only the modeling including all participants. The component
estimated parameters are shown in Table 2.8.
The output from the models and the preceding discussion align well with the fol-
lowing speculations: component three is most indicative of the individual who could
potentially develop MCI/AD within eight years of follow up, component two is some-
what indicative of individuals on trajectory to developing AD or mild impairment
and those in component one may be most likely to remain cognitively normal.
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Discussion In this chapter of the dissertation we addressed two main goals: obtain
mˆ using statistical criteria other than AIC (and including AIC for comparison pur-
poses) and determine if the mixture components obtained are predictive of future
disease status using multivariate Cox modeling and Kaplan Meier plots as validation
tools.
Derived variables from the biomarkers obtained from ADNI are used in the mix-
ture modeling process. The raw biomarker ratios are not used in a straight forward
Cox modeling approach because we wouldn’t be contributing substantial novelty to
the literature although existing studies did not exclusively focus on predicting future
status of cognitively normal persons some examined biomarker ratios. Furthermore,
we have statistical reasons to deliberately avoid the simple approach in favor of a
mixture modeling approach. These reasons are:
1. Using the raw biomarker ratios in the Cox modeling assumes a linear relation
between the log hazard function and the biomarkers which may not be the case.
2. Using raw biomarker ratios in Cox modeling will suppress the potential of un-
covering any heterogeneity in the distribution of biomarker ratios.
We also used the posterior probabilities of each individual in the Cox model instead
of the raw biomarkers because the latter is not a significant predictor of hazard rate
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(results not shown). In both the soft and hard classification Cox models, the posterior
probabilities were significant predictors of the survival of the participants whereas
the use of raw biomarker ratios yielded insignificant results (not shown). This may
suggest that the hazard function is more related to the posterior probabilities than
a linear function of the biomarkers.
Mixture modeling was chosen for the following reasons:
1. It could capture the inherent heterogeneity in the population.
2. It does not impose a linear relationship between the hazard.
3. Patterns related via the components to which persons belong can be tracked.
4. The density function of each group can be estimated and visualized.
5. Cut offs are determined automatically and thus permits us to easily compare
predicted component with true component using cross tabulation as in Table
2.9.
One,two and three component mixtures were fitted and the three statistical selection
criteria AIC, BIC and (approximated)sBIC values were. All three criteria chose mˆ = 3
as the number of components that best describe the data. It should be noted that
sBIC generally tends to choose mˆ somewhere between the two extremes (AIC and
BIC)[44] as BIC tends to be very conservative and often underestimates mˆ whereas
AIC is very liberal and may overestimate mˆ[27]. The approximated sBIC has an
additional strength of choosing the correct model given the biomarker information.
44
In this particular application, all three criteria agreed on the number of components.
A multivariate Cox model with time to MCI/AD as the output and the posterior
probabilities corresponding to the two highest risk mixture components as covari-
ates were fitted. Both posterior probabilities were significant predictors of disease
with or without adjusting for other covariates listed in the literature. We did not
find any significant interaction between the estimated posterior probabilities and the
covariates accounted for in the Cox modeling. The separation between the three
KM curves is also significant by virtue of the log rank test, and the corresponding c
statistics found are modestly high.
The study in this chapter has shown that the ratio of biomarkers may be key
in diagnosing AD vulnerability among currently cognitively normal people. To the
best of our knowledge this is the first study to apply mixture modeling techniques to
the ratio of biomarkers obtained from cognitively normal individuals for diagnostic
purposes. The model classifies individuals in the sample by separating them into one
of three categories, depending on their risk of transitioning from normal cognition in
the future.
Since this study did not incorporate potential confounders in the mixture mod-
eling process, future studies will utilize mixture regression models that account for
covariates. The rationale for such an investigation is the potential of improving the
predictive performance of the model due to the additional information. Also includ-
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ing covariates in the mixture modeling process could improve the model’s ability to
account for hidden outliers as in [46].
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2.4 Limitations and Future Directions
The data used in this chapter is a non representative sample because it came from
volunteers or people living in the US who may be concerned about the potential of
developing AD. Thus the findings from this study cannot be generalized to all per-
sons that can potentially develop AD or its related illnesses. For instance in Table
2.8 the estimated mixture proportions corresponding to components one and two
may be unlikely to mimic those that might be derived from the general population.
The reason is because we speculate that the proportion of people in the general pop-
ulation who could have been in component two were underestimated in our model
because they do not have reasons to believe that they may have AD and thus are less
likely to participate in a study like ADNI. Those who could have been in component
one were over estimated by our model because they may have been concerned about
their cognitive health and so most of them enrolled in the study. We speculate that
the third component may be comparable to that of the general population that tend
to be older but cognitively normal. Such individuals may be inclined to volunteer
for a study like ADNI and we believe that the proportion of older cognitively normal
people genuinely concerned with deteriorating cognition in the population may be
low.
In the hard classification model an individual may have been classified into a
component based on his/her posterior probability for that component being slightly
higher than a competing component. For instance an individual with posterior prob-
abilities 0.51, 0.49 and 0.0 associated with components 1,2, and 3 respectively will be
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hard classified into component 1 although this individual could have plausibly been
in component 2 as well. In our data set only two individuals had such profiles. If
the posterior probabilities were like 34%, 33% and 33% probability of belonging is
about the same for all three components, so we will classify the individual(s) into
component 1 and make a note that they could also plausibly belong to the other two
components. This case however did not arise in our data set.
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Future Directions
In this study our interest was to primarily predict transition from cognitively normal
state to either MCI or AD. Although the c-statistic (64%) obtained in our analysis is
not demonstrably superior to that of using the raw biomarker ratios in Cox modeling
(c = 63%), this study presents a paradigm to classify persons who are cognitively
normal into one of three risks strata without knowledge of their future cognitive sta-
tus.
The unsupervised learning nature of the mixture model for developing risk strata
can be developed by clinicians whose interests may lie in persons at risk today so as
to provide them with interventions; whereas such risk strata cannot be obtained from
raw biomarker ratios in a Cox model since the latter cannot be fitted without know-
ing who experienced cognitive decline, except by reference to and extrapolation from
historical strata. For instance Figure 2.11 shows the risk strata boundaries based
on the participants in this study.Importantly, given ones biomarker ratios we can
identify if this individual is at a lower, medium or high risk of developing MCI/AD
when the individual is still cognitively normal and showing no apparent symptoms
of MCI/AD by seeing where he/she falls in Figure 2.11.
Future studies will consider the transition from CN to early or late MCI and AD
as distinct events. This will however require longer follow-up times to increase the
pool of participants in the categories of MCI and AD separately. In the present study
34 (≈ 30%) participants transition from CN to either MCI or AD. This suggests that
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relatively few participants transitioned within a maximum period of eight years given
the age distribution of the study participants.
Future studies will also appeal to mixture models that adjust for other covariates
within mixture components in hope of improving on predicting MCI or AD and de-
velop a new technique to estimate mixture complexity for such models. This will be
the subject of chapter 3.
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Figure 2.3: BNM Component Membership Probability Distribution
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Figure 2.4: BNM Predicted Components Scatterplot
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Figure 2.5: BNM Component Kaplan Meier Plots
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Figure 2.6: Component contour plots
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Figure 2.7: The empty circles identify potential outliers among the eight participants
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Figure 2.8: Joint Biomarker contour plot
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Figure 2.9: Joint Biomarker density plot
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Figure 2.10: ROC plot. AUC: Area under the curve
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Figure 2.11: Risk Boundaries
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Figure 2.12: Risk Boundaries
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Figure 2.13: Risk Differentiation Boundaries
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Figure 2.14: BNM Four Component Membership Probability Distribution
64
Figure 2.15: BNM Four Component Kaplan Meier Plots
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Figure 2.16: BNM Predicted Four Component Plots
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Figure 2.17: Comparison of rtaubeta between CN and MCI/AD groups
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Figure 2.18: Comparison of rptaubeta between CN and MCI/AD groups
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Figure 2.19: Contours embedded on risk components
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Table 2.1: Table of Demographics (n=3082), standard deviation(sd), lower and upper
quartiles (Q1 and Q3), percentages may not add to 100 due to rounding
Characteristics Median(Q1,Q3) Min Max n(%)
Gender
Female - - - 779(44.9)
Male - - - 956(55.1)
Ethnicity
Hispanic/Latino - - - 58(3.3)
Non Hispanic/Latino - - - 1666(96.0)
Unknown - - - 11(0.6)
Race
American Indian/Alaskan - - - 3.00(0.17)
Asian - - - 29.00(1.67)
Black - - - 77.00(4.44)
Hawaiian - - - 2.00(0.12)
More than one - - - 18.00(1.04)
Unknown - - - 3.00(0.17)
White - - - 1603.00(92.39)
Other
Age at entry 73.9(69.2,78.9) 48.1 91.4 -
Missing values per variable - - - 1347.00(43.71)
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Table 2.2: Table of Demographics (n=114), standard deviation(sd), lower and upper
quartiles (Q1 and Q3), rptaubeta is the ratio of PTAU181P to ABETA142 and
rtaubeta is the ratio of TAU to ABETA142
Characteristics Median(Q1,Q3) Mean (sd) Min Max n(%)
Biomarkers (Units)
Tau(pg/ml) 61.00(32.00, 85.25) 69.68(30.37) 32.00 194.00 -
Abeta142(pg/ml) 217.00(75.00, 252.80) 205.60(55.09) 75.00 300.00 -
Ptau181p(pg/ml) 20.00(10.00, 28.75) 24.86(14.58) 10 83 -
Derived Biomarkers
rtaubeta 0.31(0.21,0.45) 0.39 (0.27) 0.13 1.51 -
rptaubeta 0.10(0.04,0.16) 0.14 (0.13) 0.04 0.82 -
Cognitive Test
CDRSB 0.00(0.00, 0.00) 0.06 0.00 2.50 -
MMSE baseline 29.00(29.00,30.00) 29.09 25 30.00 -
ADAS11 6.33(4.00, 8.33) 6.53 1.67 15.33 -
Gene
Apoe4 0.00(0.00,0.00) 0.24 0.00 1.00 27(24)
Race
Black - - - - 10(9)
White - - - - 104(91)
Gender
Female - - - - 56(49)
Male - - - - 58(51)
Other (Units)
Age at entry(years) 75.55(71.85,78.51) 75.51(5.2) 62.0 89.6 -
Education(years) 16.00(14.00,18.00) 15.79 6.00 20.00 -
Time(month) 54.00(36.00,90.00) 59.33(29.54) 1.00 96.00 -
Table 2.3: Selection of model complexity with three criteria
Complexity/Criteria AIC BIC sBIC
1 201.31 187.63 199.47
2 472.75 442.65 468.70
3 515.40 468.88 509.14
4 526.32 463.38 517.84
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Table 2.4: Medium/ high are respectively the component two/three rounded esti-
mated membership probabilities for the hard and soft classification. c is the con-
cordance. ** significant at 0.01 level and * significant at 0.05 level. Sample size is
n=114. HR: estimated hazard ratio, SE: standard error of log(HR), 95% CI: 95%
confidence interval, GPH Test: Global proportional hazard test
Hard classification HR SE P-value 95% CI c GPH Test
Medium|Low risk 3.02 0.41 < 0.01∗∗ (1.36, 6.68) 0.63 0.38
High|Low risk 5.35 0.53 < 0.01∗∗ (1.89, 15.15)
With Adjustment
Medium|Low risk 4.30 0.42 0.0005 (1.90, 9.76) 0.77 0.58
High|Low risk 4.49 0.55 0.006 (1.56, 13.50)
White 0.45 0.51 0.12 (0.17, 1.23)
RAVLT 0.94 0.02 0.003 (0.90, 1.98)
Soft classification
Medium|Low risk 3.32 0.46 < 0.01∗∗ (1.36, 8.13) 0.64 0.53
High|Low risk 6.15 0.54 < 0.01∗∗∗ (2.15, 17.57)
With Adjustment
Medium|Low 6.76 0.51 0.0002 (2.48, 18.40) 0.72 0.63
High|Low risk 6.45 0.65 0.0012 (2.09, 19.92)
White 0.19 0.61 < 0.01∗∗ (0.11, 0.87)
RAVLT 0.93 0.02 0.0.0017 (0.89, 0.98)
Table 2.5: Assessing CN status of Participants. Bolded observations are potential
outliers see Figure 2.7
CDRSB ADAS11 MMSE RAVLT Tau Abeta142 Ptau181p
0.50 6.67 27 36.36 44 173 15
0.50 8.00 29 30.00 97 216 32
0.50 10.33 29 40.00 48 265 13
0.50 3.33 30 33.33 53 300 13
0.50 5.00 30 30.77 37 201 11
2.50 7.00 30 71.43 119 123 59
0.50 6.67 30 7.69 86 165 43
1.00 11.00 30 100.00 61 235 18
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Table 2.6: Correlation Coefficient Matrix
Tau/Abeta Ptau/Abeta Tau Abeta Ptau
Tau/Abeta 1.00 0.74 0.85 −0.66 0.65
Ptau/Abeta 0.74 1.00 0.54 −0.65 0.92
Tau 0.85 0.54 1.00 −0.27 0.64
Abeta −0.66 −0.64 −0.27 1.00 −0.40
ptau 0.65 0.92 0.64 −0.40 1.00
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Table 2.7: Medium/ high are respectively the component two/three rounded esti-
mated membership probabilities for the hard and soft classification. c is the con-
cordance. ** significant at 0.01 level and * significant at 0.05 level. Sample size is
n=106. HR: estimated hazard ratio, SE: standard error of log(HR), 95% CI: 95%
confidence interval, GPH Test: Global proportional hazard test
Hard classification HR SE P-value 95% CI c GPH Test
Medium|Low risk 2.68 0.41 0.02 (1.19, 6.02) 0.63 0.49
High|Low risk 4.76 0.56 < 0.01∗∗ (1.58, 14.30)
With Adjustment
Medium|Low risk 2.71 0.43 0.02∗ (1.11, 6.30) 0.73 0.58
High|Low risk 3.65 0.63 0.04∗ (1.06, 12.56)
Apoe4 2.15 0.44 0.08 (0.91, 5.07)
Male 1.37 0.43 0.48 (0.58, 3.17)
White 0.23 0.60 0.02∗ (0.07, 0.76)
Baseline MMSE 1.29 0.21 0.23 (0.85, 1.96)
Education 0.99 0.07 0.87 (0.87, 1.13)
Age 0.97 0.05 0.51 (0.88, 1.06)
Soft classification
Medium|Low risk 3.39 0.48 0.01 (1.32, 8.75) 0.66 0.67
High|Low risk 6.33 0.57 < 0.01∗∗ (2.06, 19.48)
With Adjustment
Medium|Low risk 3.93 0.52 < 0.01∗∗ (1.41, 10.99) 0.74 0.63
High|Low risk 5.66 0.67 < 0.01∗∗ (1.52, 21.12)
Apoe4 1.88 0.45 0.16 (0.77, 4.56)
Male 1.33 0.43 0.51 (0.57, 3.10)
White 0.19 0.62 < 0.01∗∗ (0.06, 0.65)
Baseline MMSE 1.28 0.21 0.24 (0.84, 1.94)
Education 0.99 0.07 0.87 (0.87, 1.13)
Age 0.97 0.05 0.55 (0.89, 1.06)
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Table 2.8: Component estimated parameters. SE: standard error based on Bootstrap
sampling with B = 1000 in R mixtools package,C1-C3 are components 1 through 3.
λˆ(S Eλˆ) µˆ(S Eµˆ) Σˆ S EΣˆ
C1 0.41(0.06) 0.2235(0.0096), 0.0684(0.0027)
[
0.0029 0.0005
0.0005 0.0002
] [
0.0009 0.0002
0.0002 0.0001
]
C2 0.47(0.06) 0.3883(0.0264), 0.1282(0.0104)
[
0.0191 0.0049
0.0049 0.0028
] [
0.0052 0.0019
0.0019 0.0008
]
C3 0.12(0.03) 0.9334(0.1179), 0.4589(0.0507)
[
0.1504 -0.0303
-0.0303 0.0274
] [
0.0547 0.0181
0.0181 0.0104
]
Table 2.9: Contingency table to compare component predicted values to the true
values
Actual (%)/Predicted(%) Normal AD/MCI
Component 1 27(58.6) 19(41.3) 46
Component 2 48(84.2) 9(15.8) 57
Component 3 5(45.5) 6(54.5) 11
80 34 114
Table 2.10: Sensitivity and Specificity
Sensitivity Specificity
Component 1 or 3 2534 (74%)
48
80 (60%)
Component 3 634 (18%)
75
80 (94%)
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Chapter 3 Application of Mixture of Linear Regressions Models And the
Approximate Singular Bayesian Information Criterion
3.1 Introduction
The use of biomarkers to predict the potential of developing MCI/AD is not a new
concept. However to make such a prediction while the individuals are still cogni-
tively normal is rare in the literature. In the second chapter of this dissertation
we attempted to address this problem using mixture models without covariates to
see if the biomarker ratios by themselves can adequately predict future disease status.
In this chapter, we are interested in tapping into another form of mixture mod-
eling; mixture of regressions, to address the same scientific problem within a more
sophisticated analytical framework. Our approach is similar to [46] in that we will
regress biomarkers on covariates within each of a finite set of components. Our
analyses differ from existing ones in the following ways:
1. Unlike [46], our response variable is either trivariate or bivariate depending on
whether we use the three biomarkers or two biomaker ratios in the mixture
modeling.
2. We will also account for more than one covariate in our mixture modeling;
as a result, we will be fitting a hyperplane in each of the finite number of
components.
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3. We will determine the complexity of the mixture modeling based on two existing
model selection criteria, namely AIC and BIC,and a recently added criterion
sBIC. If there are disagreements in the estimated model complexity we will
revert to sBIC to select the correct model as sBIC has advantages over AIC and
BIC; in particular AIC is generally inconsistent as it tends to over estimate the
number of components and BIC though consistent often underestimates. Since
neither AIC nor BIC uses the correct number of parameters for the respective
penalties they impose for singular models such as mixtures, they cannot be
used to used to estimate posterior probabilities and thus cannot be used to
assess uncertainty regarding model’s correctness.
3.2 General Overview of Mixture of Regression Models With An Illus-
tration
We begin with a general overview of mixture of linear regression specific to our study
and follow-up with an example for a single subject. First we define the general
equations and the accompanying notations to be used throughout chapter three.
Yn×2 = AxBxW + εn×2Σ
1
2
2×2 (3.1)
where we assume that ε ∼ N(0, 1) and each of the entities in the model is explic-
itly defined as follows:
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Y =

y11 y12
y21 y22
y31 y32
...
...
...
...
yn1 yn2

=

YT1
YT2
YT3
...
YTn

W =

1 w11 w12 . . . w1p
1 w21 w22 . . . w2p
1 w31 w32 . . . w3p
1 w41 w42 . . . w4p
...
...
... . . .
...
...
...
... . . .
...
1 wn1 wn2 . . . wnp

=

WT1
WT2
WT3
...
WTn

β =

β01x β02x
β11x β12x
β21x β22x
β31x β32x
...
...
...
...
βp1x βp2x

=

βT0x
βT1x
βT2x
...
βTpx

78
ε =

11 12
21 22
31 32
...
...
...
...
n1 n2

=

T1
T2
T3
...
Tn

Thus for a given individual the different matrix components with complexity
m = 3 can be simplified as follows. Later in the chapter we will use these information
to illustrate how a full model structure for an individual is formulated.
A2×6 =
 a
T
1 01×3
01×3 aT1
 ,B6×2 =
B01 B11B02 B12
 ,W1×2 =
1w

C2×6 =
σ11 σ12 σ13 0 0 00 0 0 σ21 σ22 σ23
 ,Z6×2 =
a
T
1 01×3
aT1 01×3

a1 =

1x1=1
1x1=2
1x1=3

Notice from 3.1 that we have an n× 2 bivariate matrix of biomarker ratios Y and
an n× (p+ 1) matrix of covariatesW, where n is the sample size, p is the number of
coefficients not including the intercept. We assume once again that Y|X = x,W ∼
N((AxBxW),Σx) where X is a vector identifying the component membership and Bx
is an (p + 1) × 2 matrix of coefficients.
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To further clarify the set up above, we illustrate with the first set of outcomes
(y11, y12) and how it relates to the regression coefficients and the covariates, taking
into consideration the potential components that this individual could belong to.
Here y11 and y12 are respectively the first and second biomarker ratios for the first
individual. Furthermore a coefficient such as β123 will imply the slope (in the sense
of linear regression) for the main effect of the first covariate on the second biomarker
ratio in the third mixture component. Thus a general index of the form ijk will
correspond to the ith covariate effect on the jth outcome in the kth mixture component
such that i = 0, 1, 2, ..., p, j = 1, 2 and k = 1, 2, 3, ...,m. For now let us assume that
there are three components (i.e. m = 3) and assume one covariate (p = 1). Notice
that we can present this concept in a matrix form as follows:
(
y11 y12
)
= Y1 =1x1=1{β011 + β111w1} + 1x1=2{β012 + β112w1} + 1x1=3{β013 + β113w1}
1x1=1{β021 + β121w1} + 1x1=2{β022 + β122w1} + 1x1=3{β023 + β123w1}
 + ε1
Let
β01 =

β011
β012
β013
 ,β11 =

β111
β112
β113
 ,β02 =

β021
β022
β023
 ,β12 =

β121
β122
β123
 , a1 =

1x1=1
1x1=2
1x1=3

then we obtain the matrix expression
(
y11 y12
)
= Y1 =
a
T
1β01 a
T
1β02
aT1β11 a
T
1β12

1w
 + ε1
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which corresponds to the matrix in equation 3.1
Note also that from equation 3.1 the error term ε1 = ε
′Σ
1
2
x can be explicitly
presented as follows:
Σx1=1 =
σ
2
11 σ1
σ1 σ
2
21
 ,Σx1=2 =
σ
2
12 σ2
σ2 σ
2
22
 ,Σx1=3 =
σ
2
13 σ3
σ3 σ
2
23

where σ2jk is the variance of the j
th outcome in the kth component and σk is the
covariance between the jth and jth + 1 outcome in the kth component.
Letting x represent the mixture component we define the error term corresponding
to the first observation as follows:
ε1 =
(
1x1=1Σ
1
2
1 + 1x1=2Σ
1
2
2 + 1x1=3Σ
1
2
3
)
ε′1
=
(
Σ
1
2
1 Σ
1
2
2 Σ
1
2
3
)

1x1=1
1x1=2
1x1=3
 ε
′
1 (3.2)
We re-write 3.2 as follows using the matrices defined above:
ε12×1 =
σ11 σ12 σ13 0 0 00 0 0 σ21 σ22 σ23

2×6
a
T
1 01×3
aT1 01×3

6×2
ε′12×1 = CZε′1 (3.3)
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3.3 Overview of Primary Objectives
The primary objectives underscoring this chapter are as follows:
1. Use sBIC, AIC and BIC to determine the degree of complexity of a mixture of
regression modeling while accounting for race and other covariates in the mix-
ture. We will use the biomarker ratios and covariates in the mixture modeling
akin to [46].
2. We will examine the future predictive ability of the chosen model. To ac-
complish this we will compare the predicted classes into which subjects were
placed to their true future disease status so that we can address questions such
as what a person’s hazard or relative risk for developing MCI/AD is given what
we know about their current age and other covariates. Furthermore we will be
able to use their posterior probabilities to create a figure as in Figure 2.11 to
make it easier for clinicians to adequately determine an individual’s risk status.
3. Develop a risk strata plot for predictive purposes.
We begin with a graphical quick review of the biomarker ratios against selected
covariates of interest. The rationale here is to get a sense of empirical support for
the models we intend to fit. Figure 3.1 indicates that the mean biomarker ratios
for Blacks are lower than that of Whites. However both means are below the grand
mean of the biomarkers. The figure also reveals that the mean effect of race does
not statistically influence the mean effect of the biomarkers which is why the line (a
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degenerated ellipse because we have one degree of freedom) indicative of the hypoth-
esis variation is within the error variation ellipse.
Figure 3.2 however shows that Apoe4 statistically significantly influences the
mean biomarker ratios since the hypothesis variation line crosses the error variation
ellipse. As shown in the plot, carriers of Apoe4 tend to express biomarker ratios
higher than that of the grand mean whereas non-carriers tend to have lower average
biomaker ratios than the grand mean.
Figure 3.3 examines the effect of both race and Apoe4 concurrently on the
biomarker ratios. Again we notice that Apoe4 shows a significant effect whereas race
does not. Also carriers and non carriers of Apoe4 have relatively higher biomarker
ratios that are also above the grand mean than the two racial groups. Another
interesting observation from Figure 3.3 is the lack of parallelism between the two
hypothesis variations. Introducing an interaction term between apoe4 and race (plot
not shown) resulted in a much shorter hypothesis variation plot deeply embedded in
the error ellipse; an indication of an insignificant interaction between race and Apoe4.
The three plots in Figures 3.1-3.3 indicate that both race and Apoe4 influence
the biomarker ratios in the same direction and in a linear fashion. However, Apoe4
will exhibit a greater slope hence comparatively more influence on the biomarker
ratios than race as demonstrated by their respective degenerated hypothesis variation
ellipses.
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3.4 Methodologies and Overview of AIC
Participants and Cognitive Status
In chapter two we discussed the participants from the ADNI data and also explicitly
assessed the cognitive status of the participants based on the information available
in the data namely MMSE scores, CDRSB, ADAS11 and RAVLT percentage of
forgetting. From our assessment we concluded that all but eight participants in the
study can be considered cognitively normal as initially identified by ADNI. The eight
participants had questionable CDRSB scores and thus were included and excluded in
the model to measure any effect they my have. As seen in chapter two, the estimates
from the fitted model and their corresponding standard errors were all reasonably
similar and thus only the model with all the participants was reported.
In this chapter we operate on the foundation laid in chapter two; that the participants
are indeed cognitively normal and thus we work with all 114 participants.
Statistical Modeling
We use flexmix[41] an R package to model a mixture of linear regression that will
be used to classify subjects into one of a finite set of groups namely. These groups
may will be labeled for example as high risk, medium risk, intermediate risk, low risk
etc. The flexmix package assumes independence between the two response variable
of interest and fits the mixture model providing estimates such as main/interactive
effects, standard errors within each component. It also provides the variance of the
response in each component in addition to overall component prior, ratio and poste-
rior probability plot. Readers interested in knowing more about how flexmix operates
can see [41] for details.
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Similar to chapter two, we focus on using the two biomarker rations namely
rtaubeta and rptaubeta as the response variables. We will assess the collective, in-
dividual and interactive effect of the following explanatory variables in this chapter:
age, gender, race, education, APOE4 and baseline MMSE. In the interim we assume
zero covariance between rtaubeta and rptaubeta after accounting for other covari-
ates. This assumption will be duly adjusted if it fails the diagnostic test that is
developed for assessing the model’s efficacy. We also assume that the distributions
of the responses are normal by virtue of the empirical evidence in the histogram plots.
We use sBIC to ascertain the number of components and the covariates to in-
clude in the model concurrently. As a result we consider all possible combinations
of the covariates in the mixture model and then record their corresponding sBIC
values. The model with the highest sBIC value will be noted and compared with the
model with the highest change in sBIC in moving from a less complex model to a
more complex one. The final phase ensures that the resulting model has estimable
standard errors. Models that are selected by sBIC but exhibit lack of stability in
their standard errors will be traded for those with slightly lower sBIC in addition to
having stable and smaller standard errors.
The chosen model is used to obtain the posterior probability of each subject. The
raw posterior probabilities will be the soft classification of the subjects into differ-
ent risk classes given the covariates. The hard classification is obtained by selecting
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the most probable cluster of belongingness for each subject from the set of compo-
nents.The hard classification probabilities are used to obtain risk plots and survival
curves.
Cox model is used to validate the model by determining how well the posterior
probabilities predict future cognitive status of each subject. The posterior probabili-
ties corresponding to low risk as determined by the survival plot will be the baseline
in the Cox model. The performance of the prediction of the posterior probabilities
will be estimated with the c statistic that is automatically generated as part of the
Cox modeling output. Backward elimination method will be used to identify the most
influential covariates in addition to the posterior probability. The final Cox model
output is obtained for the selected covariate(s) and the corresponding c-statistic and
p-values noted. The latter model is compared with the model with only the posterior
probability as the covariate to determine which model fits the data best in terms of
predicting subjects’ transition from normal cognition. Thus we will decide between
using only the posterior probabilities in the Cox model or the posterior probability
with other significant covariates in the Cox model.
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In-consistency of AIC
Suppose that ˆAIC j denotes the AIC selected model, then we would define the
consistency of ˆAIC j as P( ˆAIC j = m0) → 1 as n → ∞. We wish to examine if this
consistency hold for AIC without structural parameters as in Charnigo and Pilla
(2007) and in a multivariate setting, given that m0 is the true model.
Let AIC1 = 2 log L1 − 2p1 and AIC2 = 2 log L2 − 2p2 be the respective AIC’s for
models 1 and 2, where 2p is penalty (which depends on the number of free parame-
ters). Then we note that AIC will choose model 1 over model 2 if AIC1 > AIC2 ⇒
2 log L1 − 2p1 > 2 log L2 − 2p2 (3.4)
⇒
2 log
L1
L2
> 2(p1 − p2) (3.5)
For a multivariate normal mixture model with structural parameter we know that
2 log L1L2
L−→ sup
θ∈Θ
(W+(θ))2 as n → ∞ when model 1 is correct where W+ is a truncated
Gaussian process as defined by Chen and Chen (2001)[4].
It follows that
P( ˆAIC j = m0) ≤ P
(
2 log
L1
L2
> 2(p1 − p2)
)
L−→ sup
θ∈Θ
(W+(θ))2 > 2(p1 − p2) (3.6)
as n → ∞ which is independent of n and thus regardless of how large n is the
probability will not approach 1.Thus P( ˆAIC j = m0) 9 1 if m0 = 1 demonstrating
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inconsistency.
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3.5 Results and Discussions
The mixture of regressions with covariate race is preferred among more than eighty
models considered. This is based on the chosen model scoring one of the highest
sBIC values for a two component mixture, presenting stable (or estimable) standard
errors and having well separated posterior plots as shown in Figure 3.4. The favored
model also has estimable standard errors within each component as demonstrated in
Table 3.2. Other two models with either apoe4 alone or Apoe4 and race as covariates
share these desirable characteristics and will be included in the following discussion.
In Table 3.1, we present the three criteria used in the model selection procedure
with our focus on the sBIC since it has ability to assess posterior probability of a
singular correctness of model unlike AIC and BIC. Table 3.1 indicates that the two
component model is preferred to a one component model by all three criteria. It
should be noted that a four component model was preferred by sBIC with covariates
age, gender and their interaction. However, this model and a similar three compo-
nent model exhibited unstable standard errors, and thus the next tier model which
has suitable characteristics in addition to high sBIC is considered instead.
Three models will now be discussed following from the latter considerations. The
first model has race as a predictor variable, the second, Apoe4, and the last both
race and Apoe4. Henceforth, these models will be referred to as race model, Apoe4
model and race and Apoe4 model respectively. Although these three models may
share similar properties in terms of the stability of standard errors and future pre-
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dictive capabilities, the model with race will be given more attention relative to the
other two due to the following reasons:
1. The race model was chosen by sBIC as the better model among the three for
consideration by assigning the model the highest value.
2. The race model has a slightly better estimated concordance statistic (67%)
as shown in Table 3.3 than its competitors (66%, and 67% for Apoe4 alone
as predictor and race+Apoe4 as predictors respectively in Tables 3.5 and 3.7)
when the high risk posterior probability alone is used in the Cox model. Notice
that the c-statistic corresponding to the model with apoe4 and race model is
the same as that in the model with race without adjustment. This shows that
using race alone is preferable if we appeal to parsimonious modeling procedures.
3. The race model exhibits comparatively better well separatedness characteristics
as demonstrated in the plot of the posterior probabilities in Figure 3.4 compared
to Figures 3.8 and 3.12 for the Apoe4 model alone and Apoe and race models
respectively . This is key in knowing how well the clusters will be distinguished
in later analysis.
4. When race alone is included in the Cox model, it was not a significant predictor
of the event. This may be expected since 91% of all the participants being Cau-
casians creates an imbalance that leads to a low power of detecting any effect.
Furthermore, this outcome also suggests that indeed the posterior probabilities
are more statistically related to the estimated hazard ratio or ones propensity
90
of transitioning from the normal state of cognition independent of race. In the
competing model, Apoe4 alone in the Cox model is a significant predictor of
the event albeit with significantly lower c-statistic(62%). Although one may
argue that 66% is indeed significantly different from 62% it still leaves room for
skepticism about the use of mixture modeling with Apoe4 if including directly
in the Cox model could produce a less complicated model that performs just
as well.
5. The risk strata obtained from the posterior probabilities associated with the
race model as shown in Figure 3.7 indicates that both biomarker ratios are
key in determining the state of cognition when race is used as the predictor
variable. Compared to the risk strata in Figure 3.11 obtained from the Apoe4
model, rtaubeta seem to be most influential in determining the strata as all
the boundaries seem to be almost vertical (this may be peculiar to the nature
of our study in that we are predicting future disease status from people who
are presently cognitively normal). This further deepens our trust in the race
model as we wish to explore the effects of both biomarker ratios in predicting
future cognitive status. Figure 3.15 depicts the risk strata plot for the race
and Apoe4 model. This plot looks similar to that of Figure 3.7 when only race
was introduced to the model. Thus if we appeal to parsimonious modeling
procedures we will prefer the race model to the race and Apoe4 model.
6. To the best of our knowledge Apoe4 has been well studied in the Alzheimer’s
Disease literature although not in the sense of mixture modeling, but little
is known about the how race might increase ones risk of getting the disease.
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Among the few existing studies Shadlen and colleagues(2006)[53] have noted
no significant differences in the risk of dementia between Black and White
subjects after accounting for confounders. Our study confirms their finding
on one hand in the sense that adjusting for race in the Cox model results in
race being a non-significant predictor of the event. However, our study also
reveals an interesting fact that race actually plays a vital role in determining
the posterior probabilities of the subjects which is a significant predictor of
the event. Here we should recognize the unique role of the mixture modeling
approach. As we have emphasized already, the mixture model approach helped
identify other roles of race in predicting future cognition that otherwise would
have been masked by using simpler analytical approaches.
We also note that the participants in the Shadlen et. al study consist of subjects
who are either cognitively normal, have incident dementia, prevalent dementia
or have MCI. Our study presents an approach to the same problem from a
strikingly different perspective stretching from the make-up of the participants
(all cognitively normal) to the methodological approaches adapted (mixture of
linear models).
As we have demonstrated above, the mixture of regression model with race as
covariate seem to embody favorable characteristics worthy of detailed study. The
model output fitted to each of the two components is displayed in Table 3.2. Com-
ponent 1 indicates that neither race nor the intercept are significant predictors of
rtaubeta. We note that being of White race has a relatively larger effect on rtaubeta
in component 1 (0.163 units) than in component 2 (0.036 units). In component two
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being White increases ones rtaubeta by about 0.04 units albeit not statistically sig-
nificant. The picture is not different when the model is fitted for rptaubeta. Once
again, race is not a significant predictor of rptaubeta in both components one and
two but its effects on rptaubeta are much greater in component one than two. A
similar trend is observed in the intercept with component one intercept being greater
than that of component two when rtaubeta or rptaubeta was the response.
Contrasting the above observation with the output from the competing models we
note that the Apoe4 model shows that Apoe4 is indeed a highly significant predictor
of both rtaubeta and rptaubeta in both components as seen in Table 3.4. Similar to
the race model, the Apoe4 model shows a greater main effect (slope) in component
one than two. When the two predictors were included in the model, Apoe4 was still
a significant predictor of both biomarker ratios adjusting for race; and race was still
not a significant predictor of the biomarker ratios in both components adjusting for
Apoe4 as shown in table 3.6. However Table 3.6 also revealed the comparable trend
of larger slopes in component one than two as indicated in the component plots in
Figure 3.5.
Figure 3.5, reinforces what we observed from the fitted models within each com-
ponent as it indicates that the relationship in component one follows a less linear
pattern than that in component two. Another observation is clear; the intercepts in
component one from Table 3.2 is much larger than that of component two for both
rtaubeta and rptaubeta respectively. This follows from the fact that we would need
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a larger intercept to fit the plot in component one than in component two.
In Figure 3.9 in many ways resembles that of Figures 3.5 and 3.13. However
Figure 3.9 classifies participants with rtaubeta between 0.5 and 0.8 into component
two whereas Figures 3.5 and 3.13 classify these participants into component one.
Thus by virtue of the Apoe4 model, having a relatively higher rtaubeta but lower
rptaubeta may not elevate ones risk of transitioning; whereas in the race model as
well as the race and Apoe4 model, such a scenario will place the participant on the
path to increased risk of transitioning.
The risk of transitioning from normal cognition in each group is shown in Figure
3.6. Component two members experience the earliest decline in cognition and the
least risk as a result of comparatively gentler decline in cognition from month 5 to
the 96th months dotted with lots of censoring. Members in component one however
experienced fewer censorship with comparatively sharper decline in cognition starting
from around months 20 to months 96. Component one membership is indicative of
comparatively latter decline in cognition around months 25 of follow-up and sharpest
decline after month 25.
In comparison to the risk plot in Figure 3.10 associated with the Apoe4 model,
the two risk components begin to separate rather earlier (about week 10) than that
of the race model or the race and Apoe4 model as shown in Figures 3.6 and 3.14
respectively. The separation between the risk groups in Figures 3.6 and 3.14 appear
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to be widening over time but this is not the case or at least not so obvious in the
risk plot of the Apoe4 model.
The Cox proportional hazard model presented in Table 3.3 shows the predictive
abilities of the soft and hard classified posterior probabilities of the race model. Based
on the risk plot in Figure 3.6 we will reference component two as the baseline risk
component. From Table 3.3 we notice from the soft classification model that when
the raw posterior probabilities are entered into the Cox model alone, the estimated
hazard ratio is 4.621(95%CI = (1.661, 12.860)). Thus the risk of transitioning from
the normal cognitive state increases by four fold if one is in component one compared
to being in component two. Adjusting for posterior probabilities for component one,
being of White race is protective against (HˆR = 0.40, 95%CI = (0.15, 1.08)) transi-
tioning from normal cognition compared to being of Black race safe that it is sta-
tistically insignificant. The corresponding c-statistic for the soft classification model
with only the posterior probabilities of component one members is 67.3% and that of
the adjusted model for immediate RAVLT is 77.6% respectively. We note here that
when race was adjusted for the c-statistic was 76.7. This may suggest that race does
not add any more information in distinguishing between those who will transition
and those who will not when the posterior probabilities are included in the model.
Of note Apoe4 was not a significant predictor (HˆR = 1.71, 95%CI = (0.88, 3.30)) of
the outcome in the presence of the risk probabilities and immediate RAVLT.
In the Apoe4 model, Apoe4 was a significant predictor of the biomarker ratios
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(Table3.4). The model also demonstrate a c-statistic of 66% when the only predictor
is the posterior probabilities in the soft classification model(Table 3.5). The hazard
of being in component one is 4.59, 95%CI = (1.844, 11.420) times that of being in
component two. Adjusting for Apoe4 increased the c-statistic modestly to 68% and
adjusting for immediate RAVLT alone also resulted in an increase in the c-statistic.
When both Apoe4 and RAVLT immediate were adjusted for, the posterior probabil-
ity (high risk) was no longer a significant predictor of the hazard (results not shown).
Notably both Apoe4 and RAVLT were significant predictors of the outcome when
the risk probabilities were eliminated from the Cox model (results not shown). Table
3.7 presents the validation for Apoe4 and race model. As seen in Table 3.6, only
Apoe4 was a significant predictor of the outcome with the two components. Table
3.7 shows that in the unadjusted model, the hazard risk associated with component
two increase 4.099, 95%CI = (1.49, 11.270) times that associated with component
one with a corresponding c statistic of 60%. Adjusting for RAVLT increased the
c-statistic to 75.9% (results not shown). Further improvements in the c-statistic
(77.2) was gained by adjusting for Apoe4 although the latter was no longer a signif-
icant predictor of the outcome (results not shown). Thus in the presence of the risk
probabilities derived from race alone or from race and Apoe4 and RAVLT, neither
race nor Apoe4 was a significant predictor of time to transition. For instance race
was a significant predictor of the outcome when RAVLT was absent from the race
and Apoe4 Cox model albeit with a significantly lower c-statistic (67%) (results not
shown).
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In the hard classification model, belonging to component one referent to compo-
nent two will significantly increase the risk of transitioning from the normal cognitive
state by 3.026, 95%CI = (1.24, 7.34). In the adjusted hard classification model, being
of White race again decreases ones risk of transitioning from normal cognition by
about 5.7% albeit statistically insignificant. We also note that the c-statistic for the
hard classification and the adjusted hard classification models are respectively 55%
and 75%. The hard classification model for Apoe4 shows also shows a reduced
effect of the posterior probabilities on the hazard (2.76, 95%CI = (1.355, 5.623))
as shown in Table 3.5. Adjusting for Apoe4 in the hard classification model re-
sulted in both the posterior probability and Apoe4 being significant predictors of
the hazard. A comparable observation can be made from the race and apoe4 hard
classification model in Table 3.7. The posterior probability had a reduced effect
(3.026, 95%CI = (1.247, 7.342)) on the hazard of transitioning. When we adjusted
for both race and Apoe4 both covariates are significant predictors of hazard ratio
but the posterior probability is not.
Further more when only race was presented in the model, being of White race
once again reduced the incidence of the event by 41%(0.49, 95%CI = (0.19, 1.26) (all
details not shown) compared to being of Black race. The associated c-statistic was
54%(S E = 0.026). This may suggest that the posterior probabilities from the mix-
ture modeling is more significantly related to the hazard function for transitioning
than the raw predictor (in this case race).
97
In addition to the aforementioned observations Figure 3.7 shows the risk strata
associated with each model for diagnostic purposes. As seen in the Figure 3.7, high
risk (H.Risk) individuals tend to have high biomarker ratios or one high and one
relatively low biomarker ratio. It is clear that an approximate lower bound for the
biomarker ratios for the hypothetically high risk individuals are about 0.7 for rp-
taubeta and about 1.25 for rtaubeta. The hypothetical intermediate risk (I.Risk)
group will have an approximate rtaubeta value range of 1.05 to below 1.25 and 0.6
to below 0.7 for rptaubeta. For the medium risk (M.Risk) group, the range for the
biomarker ratios are respectively 0.5 to below 0.6 for rptaubeta and about 0.8 to be-
low 1.05 for rtaubeta. The minimal(least) risk group (L.Risk) will exhibit biomarker
ratios below 0.5 for rptaubeta and below 0.8 for rtaubeta.
Furthermore since Figure 3.7 is a consequence of the raw posterior probabilities
whereas Figure 3.5 is a consequence of the discretized (hard classified) posterior
probabilities. The former provides a continuum (as opposed to the latter) of the
progression of risk as one advances from a minimum risk region to a high risk, thus
presenting a more plausible picture of what could be.
In contrast with Figure 3.15 is in many ways similar to that of Figure 3.5. This
may be an indication that race is more influential in the race and Apoe4 model
than Apoe4. In Figure 3.11 however, the risk strata shows that rtaubeta is more
influential in classifying individuals into the various risk layers. The plot shows that
slight changes in rtaubeta beyond 0.3 units could results in a transition with very
little influence from the rptaubeta ratio.
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Discussion
In this study we have examined the potential of adequately predicting future cognitive
status of presently cognitively normal individuals using mixture of linear regressions.
We used the ADNI database and with the help of further assessment of the cognitive
measures such as MMSE, ADAS11, RVALT and CDRSB scores, 114 participants
were confirmed as cognitively normal. We adapted the mixture of linear regressions
method for the following reasons:
1. mixture of linear regression model is more adept in handling masked out-
liers[46].
2. mixture of linear regression model affords us the flexibility needed to under-
stand the linear association between the biomarker ratios and the respective
covariate(s) within each component.
3. mixture of linear regression model like in many mixture modeling procedures
enables us to group participants that present identical characteristics and study
their risks for transitioning from the normal cognitive state.
4. when we fit the Cox model with race alone it was not a significant predictor
of the event. However the posterior probability belonging to component one
is found to be a significant predictor of the event when presented in the Cox
model. Thus the mixture modeling procedure uncovered a relationship between
the event of interest and the covariates that otherwise would have been masked.
99
5. when we fit the Cox model with the posterior probability of belonging to compo-
nent one and adjust for race, the posterior probability is found to be significant
but race is not. This may suggest that all the information needed to under-
stand the association between the event and the potential of transitioning is
captured in the relationship between the event and the posterior probabilities.
6. the concordance statistics that measures the degree of agreement between pre-
dicted and actual event indicate that the posterior probability (using race in-
directly through mixture modeling) from the mixture modeling procedure is
preferable as a measure of predicting future cognition status than using race
directly in a Cox modeling procedure.
More than eighty six models are examined with the aid of sBIC as the tool for model
selection. The models with largest sBIC and more stable standard errors are consid-
ered for further analysis.
The risk of transitioning from normal cognition within the individual components
indicate that participants in component two have the least risk with the highest risk
going to the participants in component one. This may suggest that candidates who
have low rtaubeta value and comparatively higher rptaubeta value or vice versa will
be at a medium to high risk of transitioning from normal cognition. However, if the
rptaubeta and rtaubeta values are relatively low, then the risk of transitioning is
minimal.
Figures 3.7 and 3.15 generalize the risk plot in Figures 3.5 and 3.13 and show that
having a high rptaubeta value with low rtaubeta or having a high rtaubeta keeping
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rptaubeta low both lead to an increased risk of transitioning from normal cognition.
The generalization of Figure 3.9 by Figure 3.11 is slightly different in that rtaubeta
tends to be the primary decider of the risk strata.
Furthermore, the risk strata described above can be used as a predictive mechanism
by physicians and other health practitioners based on an individual’s biomarker mea-
sures. Candidates who fall in the blue colored region based on their biomarker ratios
will have about 25% or less chance of transitioning given their biomarker ratios and
race (or biomarker ratio and Apoe4 or biomarker ratios, race and Apoe4 depending
on the model of choice). Subjects in the yellow region will be above 25% risk but
below 50% risk of transitioning given their information. Being in the brown region
increases ones risk above 50% but below 75% chance of transitioning given his/her
information. The riskiest region is denoted by red in which one has at least 75%
chance of transitioning given their information.
We speculate that the blue region may be indicative of individuals who will most
likely remain cognitively normal regardless of their race or Apoe4. Region yellow or
the intermediate region may be also indicative of a subject who will exhibit potential
signals of transitioning but may not transition and thus more likely to remain cog-
nitively normal. In the brown region we speculate that subjects are more likely to
transition than they are to remain cognitively normal. We also cautiously entertain
the possibility of the brown region being indicative of the region within which a well
targeted intervention may yield desired results since the associated risk in that region
is about the toss of a fair coin (in the neighborhood of 50%). Finally the red zone
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may be representative of subjects who will most likely transition with probabilities
well above a simple toss of a fair coin. Again we are cautiously optimistic that per-
sons who fall within this region based on their information if given the most targeted
interventions could reduce or slow their probability of transitioning out of normal
cognition.
We observe that the risk strata defined for participants who are black or white are
comparable with respect to their joint biomarker ratios. However, black participants
tend to be at a slightly higher risk for the rptaubeta ratio than the white partici-
pants (Figures 3.9-3.10). In terms of Apoe4 carriers and non-carriers, the risk strata
related to the latter seem to be driven by the rptaubeta ratio. In comparison, the
risk strata for carriers of Apoe4 are about equally influenced by the two biomarker
ratios (Figures 3.16-3.17). Given that a participant is black the risk of transitioning
associated with being non-Apoe4 carrier is primarily influenced by the rptaubeta
biomarker whereas the risk of transitioning associated with Apoe4 carriers are about
equally influenced by the two biomarkers (Figure 21-22). Given that a participant
is white the risk of transitioning for Apoe4 carriers is almost always determined by
their rptaubeta biomarker whereas the risk of transitioning for non-Apoe4 carriers
although in favor of rptaubeta biomarker is not so at values of rptaubeta lower than
0.4 (Figure 3.23-2.24).
Based on the foregone discussion, we speculate that in principle if we know a
person is white and an apoe4 carrier, the risk of transitioning in the future can solely
be determined using their baseline rptaubeta biomarker. This may not be so for non-
Apoe4 whites /blacks and apoe4 blacks in that these scenarios require knowledge on
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both biomarker ratios at baseline. Indeed these group specific diagnoses sounds the
bell that in principle the findings here may lend themselves to group specific inter-
ventions.
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3.6 Limitations and Future Directions
Limitations
In our analysis we assumed that biomarker ratios follow a normal distribution based
on the empirical evidence provided by the data via a histogram plot. Theoretically
we may be inclined to use Cauchy distribution as the biomarker ratios arise from
the ratio of two biomarkers which are assumed to be normally distributed. However
in this case the empirical evidence strongly favored normality. In addition to the
empirical evidence, the Gaussian distribution has nicer properties such as mean and
standard deviation which are both key in studying the properties of the biomarker
ratios presented here. Cauchy distribution is very limited in this sense.
We also assumed independence between the two biomarkers in our models. This
assumption arose from the fact that if we adjust for a covariate the correlation be-
tween the biomarkers will dissipate. Indeed we didn’t find any evidence that trumps
our assumption so much so that we had to change course. It is worth mentioning that
conditioning on the covariates such as race or Apoe4 or both reduced the correlation
between the outcomes.
Furthermore, only 10 of the 114 participants were Black which may bias the race
model outcome due to lack of power as the proportion of Black and White will be
very different. However the standard errors produced by the race model exhibited
stable properties which is non-indicative of biasedness.
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Future Direction
In future studies we hope to access more events due to longer follow up periods in
the ADNI studies. In this study we had 34 events thus far. Longer follow-up could
yield more events which will increase the power of the study.
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Figure 3.1: Relationship between biomarkers ratios and race. + represents the grand
mean
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Figure 3.2: Relationship between biomarker ratios and Apoe4 + represents the grand
mean
107
Figure 3.3: Relationship between biomarkers, race and Apoe4. + is grand mean.
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Figure 3.4: Joint Distribution of rtaubeta and rptaubeta Given Race
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Figure 3.5: Posterior probability plot with race as predictor in the mixture regression
model indicates that the model is well separated
110
Figure 3.6: Individual biomarker ratios grouped into different risk regions. Here race
is the predictor variable
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Figure 3.7: The survivability of the two groups over time given in weeks. Here race
is the predictor variable
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Figure 3.8: Risk strata for Blacks from the posterior probabilities obtained from the
mixture of linear regression with race as covariate
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Figure 3.9: Risk strata for Whites from the posterior probabilities obtained from the
mixture of linear regression with race as covariate
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Figure 3.10: Joint Distribution of rtaubeta and rptaubeta Given Apoe4
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Figure 3.11: Posterior probability plot indicates that the mixture of regression model
with Apoe4 as predictor model is comparatively less well separated
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Figure 3.12: Individual biomarker ratios grouped into different risk regions. Here
Apoe4 is the predictor variable.
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Figure 3.13: The survivability of the two groups over time given in weeks. Here
Apoe4 is the predictor variable.
118
Figure 3.14: This corresponds to the risk strata for Apoe4 carriers derived from the
posterior probabilities obtained from the mixture of linear regression with Apoe4 as
predictor variable.
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Figure 3.15: This corresponds to the risk strata for none-Apoe4 carriers derived from
the posterior probabilities obtained from the mixture of linear regression with Apoe4
as predictor variable.
120
Figure 3.16: Posterior probability plot indicates that the model with Apoe4 and race
as predictors is comparatively less well separated
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Figure 3.17: Individual biomarker ratios grouped into different risk regions. Here
Apoe4 and race are the predictor variables.
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Figure 3.18: The survivability of the two groups over time given in weeks. Here
Apoe4 and race are the predictor variables.
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Figure 3.19: Risk strata for black who are apoe4 carriers obtained from the mixture
of linear regression with Race and Apoe4 as covariates
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Figure 3.20: Risk strata for blacks who are none-apoe4 carriers obtained from the
mixture of linear regression with Race and Apoe4 as covariates
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Figure 3.21: Risk strata for whites who are apoe4 carriers obtained from the mixture
of linear regression with Race and Apoe4 as covariates
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Figure 3.22: Risk strata for whites who are none-apoe4 carriers obtained from the
mixture of linear regression with Race and Apoe4 as covariates
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Table 3.1: Selection of model complexity with three criteria. To calculate the learn-
ing coefficient sBIC, we are assuming the non-redundant one component. Numbers
shown are differences between the information criteria at one component versus the
information criteria at two component.
Complexity/Criteria AIC BIC sBIC
1-2 535.35 502.52 530.94
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Table 3.2: Estimates of the regression models within each component.Race is the
only predictor variable in the model. Race is an indicator variable for Caucasian
(coded as 1) and the referent group is black (coded as zero) *** significant at 0.001
level, ** significant at 0.01 level and * significant at 0.05 level
Component 1 for rtaubeta Estimate SE P-value
Intercept 0.563 0.315 0.074
Race 0.163 0.322 0.613
Component 2 for rtaubeta
Intercept 0.238 0.031 < 0.001∗∗∗
Race 0.036 0.034 0.282
Component 1 for rptaubeta Estimate SE P-value
Intercept 0.266 0.169 0.115
Race 0.039 0.172 0.819
Component 2 for rptaubeta
Intercept 0.080 0.011 < 0.001∗∗∗
Race 0.009 0.012 0.443
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Table 3.3: High|Low risk is component one estimated probability for the soft and
hard classification models. c is the concordance.HR is the hazard ratio. Race is
the only predictor. When model was adjusted for education, MMSE, and age only
prop.SBICO1 and rprop.SBICO1 were significant. This significance disappeared
when Apoe4 was adjusted for (results not shown)
Soft classification Estimated HR P-value CI c(SE)
High|Low risk 4.621 0.001 (1.661, 12.860) 0.680(0.058)
With Adjustment
High|Low risk 3.98 0.001 (1.693, 9.369) 0.776(0.058)
RAVLT 0.95 0.007 (0.912, 0.986)
Hard classification
High|Low risk 3.026 0.014 (1.24, 7.34) 0.547(0.026)
With Adjustment
High|Low risk 3.016 0.003 (1.460, 6.228) 0.745(0.057)
Race 0.943 0.003 (0.908, 0.980)
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Table 3.4: Estimates of the regression models within each component. Apoe4 is the
only predictor variable in the model.Apoe4 is coded as 1 for carriers of the gene and
0 for non carriers. *** significant at 0.001 level, ** significant at 0.01 level and *
significant at 0.05 level
Component 1 for rtaubeta Estimate SE P-value
Intercept 0.562 0.065 < 0.001∗∗∗
Apoe4 0.307 0.108 0.005∗∗
Component 2 for rtaubeta
Intercept 0.247 0.012 < 0.001∗∗∗
Apoe4 0.106 0.026 < 0.001∗∗∗
Component 1 for rptaubeta Estimate SE P-value
Intercept 0.217 0.032 < 0.001∗∗∗
Apoe4 0.192 0.054 < 0.001∗∗∗
Component 2 for rptaubeta
Intercept 0.078 0.004 < 0.001∗∗∗
Apoe4 0.034 0.008 < 0.001∗∗∗
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Table 3.5: High|Low risk is component one estimated probability for the soft and
hard classification models. c is the concordance. HR is the hazard ratio. Apoe4 is
the only predictor variable. When model was adjusted for education, MMSE, race
and age only prop.SBICO12 and race or rprop.SBICO12 were significant (results not
shown)
Soft classification Estimated HR P-value CI c(SE)
High|Low risk 4.590 0.001∗∗ (1.844, 11.420) 0.662(0.058)
With Adjustment
High|Low risk 4.758 0.005 (1.976, 11.58) 0.764(0.058)
RAVLT 0.942 0.002 (0.907, 0.979
Hard classification
High|Low risk 2.760 0.001 (1.355, 5.623) 0.586(0.039)
With Adjustment
High|Low risk 2.108 0.110 (0.844, 5.263) 0.69(0.057)
RAVLT 0.951 0.013 (0.914, 0.990)
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Table 3.6: Estimates of the mixture of regression models within each component.
*** significant at 0.001 level, ** significant at 0.01 level and * significant at 0.05
level
Component 1 for rtaubeta Estimate SE P-value
Intercept 0.255 0.264 0.333
Race 0.312 0.260 0.230
Apoe4 0.335 0.109 < 0.01∗∗
Component 2 for rtaubeta
Intercept 0.213 0.031 < 0.001∗∗∗
Race 0.039 0.032 0.221
Apoe4 0.108 0.025 < 0.001∗∗∗
Component 1 for rptaubeta Estimate SE P-value
Intercept 0.079 0.127 0.537
Race 0.141 0.125 0.263
Apoe4 0.206 0.053 < 0.001∗∗∗
Component 2 for rptaubeta
Intercept 0.072 0.009 < 0.001∗∗∗
Race 0.008 0.010 0.432
Apoe4 0.035 0.008 < 0.001∗∗∗
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Table 3.7: prop.SBIC013 is component one estimated probability and rprop.SBIC013
is component one hard classification. c is the concordance. HR is the hazard ratio.
Race and Apoe4 are the predictors. When model was adjusted for education, MMSE,
race and age only Apoe4 was significant (results not shown)
Soft classification Estimated Hazard P-value CI c(SE)
prop.SBIC013 4.099 0.006 (1.490, 11.270) 0.599(0.058)
With Adjustment
prop.SBIC013 2.863 0.058 (0.967, 8.480) 0.670(0.058)
Race 0.380 0.052 (0.143, 1.009)
Apoe4 2.312 0.036 (1.056, 5.066)
Hard classification
rprop.SBIC013 3.026 0.014 (1.247, 7.342) 0.547(0.026)
With Adjustment
rprop.SBIC013 2.345 0.083 (0.895, 6.145) 0.634(0.046)
Race 0.373 0.048 (0.140, 0.993)
Apoe4 2.366 0.029 (1.093, 5.119)
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3.7 Illustrative Computations for A1-A3 in Drton and Plummer(2016)
for Mixture of Regression Models
Adapting some of the notations from Dacunha-Castelle and Gassiat(1999)[55] we
define a family of mixture of regression models as:
Gk =
g = g(yi|xi,Θ j) = k∑
j=1
pi j f j(yi|xi,Θ j)
 (3.7)
where xi is the vector of covariates for subject i, Θ j is the component specific pa-
rameters (i.e. Θ j =
(
β j,Σ j
)
) and pi j are the mixing proportions or weights such that
0 ≤ pi j ≤ 1 and ∑kj=1 pi j = 1. Furthermore we assume that the Σ j are positive defi-
nite and their eigenvalues are bounded away from zero. That is ∃  > 0 such that
min{ev
(
Σ j
)
} ≥  > 0.
Assume that
X ∼ N(µ, τ2)
and
Y|X=x, β, σ2 ∼ N(β0 + β1x, σ2).
Then var(Y) = var(E(Y |X)) + E(var(Y |X)) = β21τ2 + σ2. The covariance is also given
as cov(X,Y) = corr(X,Y) ∗ √var(X)var(Y) = Rτ
√
β21τ
2 + σ2 noting from the standard
regression slope formula that β1 = R
sy
sx
= R
√
β21τ
2+σ2
τ
⇒ R = βˆ1τ√
β21τ
2+σ2
. Here forward we
will adapt the notation r = R. The joint distribution is given as:
X,Y|τ2, σ2, β0, β1, µ ∼ N

 µβ0 + β1µ
 ,
 τ
2 rτ
√
β21τ
2 + σ2
rτ
√
β21τ
2 + σ2 σ2 + τ2β21

 . (3.8)
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X,Y|τ2, σ2, β0, β1, µ ∼ N

 µβ0 + β1µ
 ,
 τ
2 β1τ
2
β1τ
2 σ2 + τ2β21

 . (3.9)
The rationale for the above assumptions and the subsequent derivation of the joint
density of X and Y is to be able to invoke assumptions P0 and P1 in Dacunha-Castelle
and Gassiat (1999) which assumed a parametric family of marginal densities. Our
original density is conditional on X and so to arrive at the joint distribution we notice
by elementary conditional probability that f (y|x) = f (x,y)f (x) .
Note that
Gk =
g = k∑
j=1
pi j
f (xi, yi|θ j)
f (xi|K)
 ,
where θ j = (β j, τ2, σ2) and K = (µ, τ2) The corresponding log likelihood of the family
of conditional densities defined above is:
ln(g) =
n∑
i=1
ln
k∑
j=1
pi j f (yi|xi, θ j) =
n∑
i=1
ln
k∑
j=1
pi j
f (xi, yi|θ j)
f (xi|K) =
n∑
i=1
ln
1
f (xi|K)
k∑
j=1
pi j f (xi, yi|θ j)
Assuming a q mixture component under the null hypothesis we have that
f0 =
q∑
j=1
pi j0
f (xi, yi|θ j0,K0)
f (xi|K0) ,
for some parameters K0, θ j0 and pi j0 respectively and θ j0 is the true value of θ j. Define
a statistic based on the log likelihood as: Tn(k) = sup
g∈Gk
ln(g) − ln( f0), then the LRT
statistic for testing a q mixture component versus a k mixture component can be
defined based on Tn as follows: Vn = Tn(k) − Tn(q). In essence Vn is:
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Vn = sup
g∈Gk
n∑
i=1
ln
1
f (xi|K)
k∑
j=1
pi j f (xi, yi|θ j) − sup
g∈Gq
n∑
i=1
ln
1
f (xi|K)
q∑
j=1
pi j f (xi, yi|θ j)
=
n∑
i=1
ln 1f (xi|Kˆ0)
k∑
j=1
pi j f (xi, yi|θˆ j) − ln 1
f (xi|Kˆ0)
q∑
j=1
pi j0 f (xi, yi|θˆ j0)

=
n∑
i=1
− ln f (xi|Kˆ0) + ln k∑
j=1
pi j f (xi, yi|θˆ j) + ln f (xi|Kˆ0) − ln
q∑
j=1
pi j) f (xi, yi|θˆ j0)

=
n∑
i=1
ln k∑
j=1
pi j f (xi, yi|θˆ j) − ln
q∑
j=1
pi j0 f (xi, yi|θˆ j0)

Based on the latter results, testing on the conditional densities is equivalent to testing
on the marginal densities.
Recall that:
f (w|Σ,Γ) = 1
(2pi)dim(w)/2|Σ|0.5 exp
{
−0.5(w − Γ)TΣ−1(w − Γ)
}
where
w =
xy
 ,
Γ =
 µβ0 + β1µ
 ,
Σ =
 τ
2 β1τ
2
β1τ
2 σ2 + τ2β21

We now want to show that ∃ h(x, y) and  ∈ (0, 1) such that |ln f (x, y|Σ,Γ)|≤ h(w) =
h(x, y) where Eh(X,Y) < ∞ assuming that 1

≥ τ2 ≥  > 0, 1

≥ σ2 ≥  > 0, −1

≤ µ ≤ 1

,
−1

≤ β0 ≤ 1 , −1 ≤ β1 ≤ 1 and −1 ≤ β0 + β1µ ≤ 1 .
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2|ln f (w|Σ,Γ)|=
∣∣∣∣∣ ln 2pi− ln|Σ|−(w−Γ)TΣ−1(w−Γ)∣∣∣∣∣ ≤ |ln 2pi|+|ln|Σ||+||(w−Γ)TΣ−1(w−Γ)||
≤ c1 + c2 + ||(w − Γ)TΣ−1(w − Γ)|| (3.10)
where c1 = ln 2pi and
|ln|Σ||= |ln ((τ2σ2 + τ4β21) − β21τ4)|= |lnσ2τ2|≤ |ln 4|= 4|ln  |= c2. (3.11)
Furthermore by applying the Cauchy-Schwartz inequality and the induced norm we
have that
||(w − Γ)TΣ−1(w − Γ)||≤ ||(w − Γ)TΣ−1|| ||(w − Γ)||≤ ||(w + (−Γ))T || ||Σ−1|| ||(w + (−Γ))||
≤ (||wT ||+||ΓT ||)||Σ−1||(||w||+||Γ||) (3.12)
where
||ΓT ||= ||Γ||=
√
µ2 + (β0 + β1µ)2 ≤
√
1
2
+
(
1

+
1
2
)2
= c3 (3.13)
also applying the Frobenius norm (norm of a matrix) we get
||Σ−1||≤ ||Σ−1||F=
√
tr(Σ−1TΣ−1) =
√
tr(Σ−1Σ−1). (3.14)
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We note that
Σ−1Σ−1 =

1
τ2
+
β21
σ2
−β1
σ2
−β1
σ2
1
σ2


1
τ2
+
β21
σ2
−β1
σ2
−β1
σ2
1
σ2
 =

(
1
τ2
+
β21
σ2
)2
+
β21
σ4
−β1
τ2σ2
− β31+β1
σ4
−β1
τ2σ2
− β31+β1
σ4
β21+1
σ4

⇒ tr(Σ−1Σ−1) = 1
τ4
+
2β21
τ2σ2
+
β41 + 2β
2
1 + 1
σ4
⇒ ||Σ−1||F=
√
tr(Σ−1TΣ−1) =
√
1
τ4
+
2β21
τ2σ2
+
β41 + 2β
2
1 + 1
σ4
≤
√
1
4
+
2/2
4
+
1/4 + 2/2 + 1
4
=
√
1
8
+
4
6
+
2
4
= c4 (3.15)
Thus from above we let
h(w) = c1 + c2 + c4(||wT ||+c3)(||w||+c3) = c1 + c2 + c4(||wT || ||w||+2c3||w||+c23), (3.16)
which depends only on w and let E f1(.) denote the expectation with respect to say
f1(w). Assuming the true parameters at the null are respectively γ0 = (µ0, τ0, β00, β10, σ0)
and fo =
∑q
i=1 pii fi0 it follows that"
h(w) f0(w|γ0)dw = pi1
"
h(w) f10(w|γ0)dw + ... + piq
"
h(w) fq0(w|γ0)dw
= pi1E f1(h(w)) + ... + piqE fq(h(w)) (3.17)
Then the first expectation can be evaluated as follows:
pi1E f1(h(w)) = pi1
{
c1 + c2 + c4E(W21 + W
2
2 ) + 2c3c4E
(√
W21 + W
2
2
)
+ c4c23
}
< ∞, (3.18)
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since in a general setting as in E(WT1 W1 + ...+W
T
pWp) = E(W
T
1 W1)+ ...+E(W
T
pWp) and
in particular W1 = [X,Y], then E(WT1 W1) = E(X
2
1 + Y
2
1 ) = var(X1) + E(X1)
2 + var(Y1) +
E(Y1)2 = τ2 + µ2 + σ2 + τ2β21 + (β0 + β1µ)
2 and p is the number of rows in W.
It also follows by Jensen’s inequality and the concavity of the square root function
that E
(√
WT1 W1 + ... + W
T
pWp
)
≤
√
E(WT1 W1 + ... + W
T
pWp) =
√
E(WT1 W1) + ... + E(W
T
pWp).
Specifically for p = 2,
E
(√
WT1 W1
)
≤
√
E(WT1 W1)
=
√
τ2 + µ2 + σ2 + τ2β21 + (β0 + β1µ)
2 ≤
√
4
2
+
1
4
< ∞ (3.19)
by virtue of our assumptions on the parameters. So we have that,
2|ln f (w|Σ,Γ)|≤ h(w) =⇒ |ln f (w|Σ,Γ)|≤ h(w), (3.20)
where E(h) ≤ ∞
Furthermore, we note that f (w|Σ,Γ) possesses partial derivatives up to the order
5 and that ∀z ≤ 5,
Dzi1...iz f (w|Σ0,Γ0)
f0
∈ L3( f0ν), (3.21)
where i1...iz indexes the densities of the function f (w|Σ0,Γ0) and z the order of deriva-
tive being taken with respect to the parameters in question. So if for instance i1 = i2
and z = 2 then the numerator of the expression above will yield the second derivative
with respect to one parameter. In particular we will have for example, that
D2γ0γ0 f (w|Σ0Γ0)
f0
=
∂2 f (w|γ0)
∂γ20
f0
, (3.22)
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which is the second derivative of the function with respect to γ0. On the other hand
if i1 , i2 and z = 2 then we take the partial derivative with respect to say β1 first and
then µ second getting a mixed partial derivative.
To see why eq(11) holds (here we suppress the dependence on component l in our
notation), consider the following expansions:
(w − Γ)TΣ−1(w − Γ) =
 x − µy − (β0 + β1µ)

T 
1
τ2
+
β21
σ2
−β1
σ2
−β1
σ2
1
σ2

 x − µy − (β0 + β1µ)

= (x − µ)2
(
1
τ2
+
β21
σ2
)
+
−2β1
σ2
(x − µ)(y − (β0 + β1µ)) + 1
σ2
(y − (β0 + β1µ))2 (3.23)
Thus the density can be expressed as:
f (w|Σ,Γ)
∝ 1
τσ
exp
{
−0.5
(
(x − µ)2
(
1
τ2
+
β21
σ2
)
+
−2β1
σ2
(x − µ)(y − (β0 + β1µ)) + 1
σ2
(y − (β0 + β1µ))2
)}
(3.24)
We verify that the general derivative (D) of the density as defined above is of the
form Df = f (x, y|σ, τ, µ, β1, β0) ∗ polynomial where the plynomial is in terms of x − µ
and y where all parameters are expressed as rational functions. This will be clarified
below.
To see why we let v = 1/σ, s = 1/τ and notice that f can be written as:
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f (x, y|σ, τ, µ, β1, β0) ∝
vs exp
{
− 0.5
[
(x − µ)2(s2 + v2β21) − 2v2β1(x − µ)(y − (β0 + β1µ)) + v2(y − (β0 + β1µ))2
]}
We begin with the first derivative to form the foundation of the derivatives and
then proof by induction that the proposed pattern holds true for all higher order and
mixed derivatives. For simplicity we shall use f to represent the function defined
above and D to represent the derivative with respect to the parameter of interest
expressed as a subscript. In that respect we will have that:
Dβ1 f = f ∗
[
− v2β1(x − µ)2 + (x − µ)
{
v2(y − (β0 + β1µ)) − v2β1µ
}
+ µ(y − (β0 + β1µ))
]
which is of the form f ∗ polynomial in x − µ.
Dβ0 f = f ∗
[
− v2β1(x − µ) + v2µ(y − (β0 + β1µ))
]
which is of the form f ∗ polynomial in x − µ.
Dµ f = f ∗
[
(x − µ)
{
(s2 + v2β21) − v2β21
}]
which is of the form f ∗ polynomial in x − µ.
D 1
σ
f = Dv f = f ∗
[
− vβ21(x−µ)2 + 2vβ1(x−µ)(y− (β0 + β1µ))− v(y− (β0 + β1µ))2 +
1
v
]
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which is of the form f ∗ polynomial in x − µ.
D 1
τ
f = Ds f = f ∗
[
− s(x − µ)2 + 1
s
]
which is of the form f ∗ polynomial in x−µ. Without loss of generality we shall define
the polynomial as follows:
λ∑
j=0
t∑
r=0
cr(γ)xt−ryλ− j (3.25)
The foregone derivatives above are all of the form f ∗ polynomial in x, y, where
c(γ)′s are polynomial collections and rational functions of γ. Next we assume that
this observation holds true for all derivatives in the sense that the derivative of the
form f ∗ polynomial regardless of the parameter of interest yields a similar format
f˜ ∗ ˜polynomial in that taking the derivative of a polynomial yields a polynomial and
the derivative of f gives the product of f and a polynomial.
Mathematically we assume that
Di1,...,iz−1 f = f ∗ polynomial
where the polynomial is in terms of x and y. To maximize the polynomial we note
that γ is restricted to a compact region in the sense of ||γ − γ0||≤  and also recall
that Cr(γ) is a rational function of the form
Cr(γ) =
Pr(γ)
vδ, s∆
,∆ ≥ 0, δ ≥ 0,
where Pr(γ) is a polynomial function in γ. However as we have mentioned above γ
is in a compact region and since the polynomial function Pr(γ) is continuous with
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respect to γ vis a vis ||γ − γ0||≤ , ∃ M() ≥ 0 for which |Pr(γ)|≤ M(). In addition we
recall from previous assumptions that 1s ≤ 1 and 1v ≤ 1 and it follows that:
Cr(γ) =
Pr(γ)
vδ, s∆
≤ M()
δ+∆
< ∞,
which in turn ensures that the polynomial
λ∑
j=0
t∑
r=0
cr(γ)xt−ryλ− j < ∞
In a broader sense if we let g = x and γ = β0, β1, σ, τ, µ then we are specifically
assuming that
Di1,...,iz−1 f = f ∗ [c1(γ)gtyλ + c2(γ)gt−1yλ−1 + ... + cr(γ)]
for an rth term polynomial with degree t + λ.
We proceed to show that all the derivatives (both mixed and otherwise) of
Di1,...,iz−1 f = f ∗ polynomial are also of the similar form f ∗∗ ∗ polynomial∗∗
Diz(Di1,...,iz−1 f ) = Diz
[
f ∗ [c1(γ)gt + c2(γ)gt−1 + ... + cr(γ)
]
= Diz
(
f ∗ c1(γ)gtyλ
)
+ ... + Diz
(
f ∗ cr(γ)
)
=
{
[Diz f ] ∗ c1(γ)gtyλ + f ∗ [Dizc1(γ)gtyλ]
)
+ ... + [Diz f ] ∗ cr(γ) + f ∗ [Dizcr(γ)]
)}
= f ∗polynomial∗c1(γ)gt+ f [Diz(c1(γ))gtyλ+(Dizgtyλ)c1(γ)+...+ f ∗polynomial∗cr(γ)+ f ∗Diz(cr(γ))
= f
[
polynomial∗c1(γ)gtyλ+[Diz(c1(γ))gtyλ+(Dizgtyλ)c1(γ)+...+polynomial∗cr(γ)+
∂
∂iz
cr(γ)
]
= f ∗ polynomial = f (x, y|σ, τ, µ, β1, β0)
λ∑
j=0
t∑
r=0
cr(γ)xt−ryλ− j
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Based on the derivations above we have that
Dzi1,...,iz f |γ0
f0
=
fl0 ∗ polynomial
pi1 f10 + ... + piq fq0
≤ fl0 ∗ polynomial
pil fl0
=
1
pil0
∗ polynomial
=
1
pil0
λ∑
j=0
t∑
r=0
cr(γ)xt−ryλ− j
with respect to x, y and coefficients c(γ) which are rational functions of γ0. Since
E(|X|p) < ∞ and E(|Y |p) < ∞ it follows that∫ ∫ ∣∣∣∣∣Dzi1,...,iz f |γ0f0 ∣∣∣∣∣1/3 f (x, y|γ0)dxdy ≤ (
∫ ∫ ∣∣∣∣∣ 1pil0 λ∑j=0 t∑r=0 cr(γ0)xt−ryλ− j∣∣∣∣∣3 f (x, y|γ0))1/3dxdy < ∞
Next we show that there exists an H5(x, y) such that
sup
||γ−γ0 ||≤
∣∣∣∣∣D5i1,...,i5 fγf0
∣∣∣∣∣ ≤ H5(x, y),
and E f0(H
3
5(X,Y)) < +∞.
Recall that f (x, y) = vs exp {−0.5[(x − µ)2(s2 + v2β21) − 2v2β1(x − µ)(y − β¯) + v2(y − β¯)2]}
where β¯ = β0 + β1µ.
Also recall that f0 =
∑q
i=1 pii fi(x, y) which we shall represent as f0 = pi1 f1 + . . . + piq fq
To show the P0, we notice that
∣∣∣∣∣D5 fγrf0 ∣∣∣∣∣3 = ∣∣∣∣∣ D5 fγrpi1 f1+...+piq fq ∣∣∣∣∣3 ≤ ∣∣∣∣∣D5 fγrpir fr ∣∣∣∣∣3, for r ≤ q, where D is
an arbitrary partial derivative, fγr is the nearby and fr = fγr0 is the true density for
component r. In the subsequent proof, expressions without subscripts are the nearby
quantities and those with subscripts are the true quantities.
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But∣∣∣∣∣Dfγrpir fr
∣∣∣∣∣
≤
vs exp {−0.5[(x − µ)2(s2 + v2β21) − 2v2β1(x − µ)(y − β¯) + v2(y − β¯)2]}M()
∣∣∣∣∣ ∑λj=0 ∑tr=0 xt−ryλ− j∣∣∣∣∣
pirvrsr exp {−0.5[(x − µ)2(s2r + v2rβ21r) − 2v2β1r(x − µr)(y − β¯r) + v2(y − β¯r)2]}
=
vs
pirvrsr
exp
(
− 0.5
[
(x − µ)2(s2 + v2β21) − (x − µr)2(s2r + v2rβ21r) − 2v2β1(x − µ)(y − β¯)
+2v2rβ1r(x − µr)(y − β¯r) + v2(y − β¯)2 − v2r (y − β¯r)2
])
M()
∣∣∣∣∣ λ∑
j=0
t∑
r=0
xt−ryλ− j
∣∣∣∣∣
=
vs
pirvrsr
exp
(
− 0.5
[
x2{(s2 + v2β21) − (s2r + v2rβ21r)} + x{−2µ(s2 + v2β21) + 2µr(s2r + v2rβ21r)}
µ2(s2 + v2β21) − µ2r (s2 + v2β21) + xy[−2v2β1 − 2v2rβ1r]
x[−2v2β1β¯ + 2v2β1rβ¯r] + y[2v2β1µ − 2v2rβ1rµr]
µ[−2v2β1β¯ + 2v2rβ1rβ¯r] + y2[v2 − v2r ] + y[−2v2β¯ + 2v2r β¯] + (v2β¯2 − v2r β¯2r )
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+2v2rβ1r(x − µr)(y − β¯r) + v2(y − β¯)2 − v2r (y − β¯r)2
])
∗ M()
∣∣∣∣∣ λ∑
j=0
t∑
r=0
xt−ryλ− j
∣∣∣∣∣
=
vs
pirvrsr
exp
(
−0.5
[
x2{(s2+v2β21)−(s2r+v2rβ21r)}+x{−2µ(s2+v2β21)+2µr(s2r+v2rβ21r)−2v2β1β¯+2v2β1rβ¯r}
xy[−2v2β1 − 2v2rβ1r] + y2[v2 − v2r ] + y[2v2β1µ − 2v2rβ1rµr − 2v2β¯ + 2v2r β¯]
µ2(s2 + v2β21) − µ2r (s2 + v2β21) + µ[−2v2β1β¯ + 2v2rβ1rβ¯r]
+(v2β¯2 − v2r β¯2r )
])
∗ M()
∣∣∣∣∣ λ∑
j=0
t∑
r=0
xt−ryλ− j
∣∣∣∣∣
= exp
(
− 0.5
[
ax2 + bx + cxy + dy2 + ey + f
])
∗ M()
∣∣∣∣∣ λ∑
j=0
t∑
r=0
xt−ryλ− j
∣∣∣∣∣,
where
a = −0.5
[
(s2+v2β21)−(s2r+v2rβ21r)
]
, b = −0.5
[
−2µ(s2+v2β21)+2µr(s2r+v2rβ21r)−2v2β1β¯+2v2β1rβ¯r
]
c = −0.5
[
−2v2β1−2v2rβ1r
]
, d = −0.5
[
v2−v2r
]
, e = −0.5
[
2v2β1µ−2v2rβ1rµr−2v2β¯+2v2r β¯
]
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f = −0.5
[
µ2(s2+v2β21)−µ2r (s2r +v2rβ21r)+µ[−2v2β1β¯+2v2rβ1rβ¯r]+(v2β¯2−v2r β¯2r )+log
( vs
pirvrsr
)]
Now assuming that ||µ−µr||≤ , ||τ2−τ2r ||≤ , ||σ2−σ2r ||≤ , ||β1−β1r||≤ , ||β0−β0r||≤ ,
||β¯− β¯r||≤ , ||s2 − s2r ||≤ , ||v2 − v2r ||≤ , ||s− sr||≤ , and ||v− vr||≤  then we can find the
respective maximum and minimum expressions for a, b, . . . , f .
For we notice that∣∣∣∣∣0.5[(s2 + v2β21) − (s2r + v2rβ21r)]∣∣∣∣∣ ≤ ∣∣∣∣∣s2 − s2r ∣∣∣∣∣ + ∣∣∣∣∣v2β21 − v2rβ21r∣∣∣∣∣
≤
∣∣∣∣∣(s2r + ) − s2r ∣∣∣∣∣ + ∣∣∣∣∣(v2 + )(β21r + ) − v2rβ21r∣∣∣∣∣
=  +
∣∣∣∣∣v2r + β21r + 2∣∣∣∣∣ = amax,
similarly we can obtain a maximum for b as follows:
∣∣∣∣∣0.5[ − 2µ(s2 + v2β21) + 2µr(s2r + v2rβ21r) − 2v2β1β¯ + 2v2β1rβ¯r]∣∣∣∣∣
≤
∣∣∣∣∣µs2 − µrs2r ∣∣∣∣∣ + ∣∣∣∣∣µrv2β21 − µrv2rβ21r∣∣∣∣∣ + ∣∣∣∣∣v2β1β¯ − v2β1rβ¯r∣∣∣∣∣
≤
∣∣∣∣∣(µr ± )(s2r + ) − µrs2r ∣∣∣∣∣ + ∣∣∣∣∣(µr ± )(v2r + )(β21r + ) − µrv2rβ21r∣∣∣∣∣
+
∣∣∣∣∣(v2r + )(β1r ± )(β¯r ± ) − v2β1rβ¯r∣∣∣∣∣
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=∣∣∣∣∣(µr ± sr + )∣∣∣∣∣ + ∣∣∣∣∣(µrβ21r ± v2rβ21r ± β21r + µrv2r + µr ± v2r ± 2)∣∣∣∣∣
+
∣∣∣∣∣(β¯rβ1r±v2r β¯r ± β¯r ± v2rβ1r + v2r ± β1r + 2)∣∣∣∣∣
≤ bmax,
Following similar derivations we obtain the following maximums:
∣∣∣∣∣0.5(−2v2β1 − 2v2rβ1r)∣∣∣∣∣ ≤ |(v2r + )(β1r ± ) − v2rβ1r∣∣∣∣∣ ≤ ∣∣∣∣∣(v2r + β1r + )∣∣∣∣∣ ≤ cmax,
|0.5(v2 − v2r )|≤ |(v2r + ) − v2r |= | |= dmax,
∣∣∣∣∣0.5[2v2β1µ − 2v2rβ1rµr − 2v2β¯r + 2v2r β¯∣∣∣∣∣ ≤ ∣∣∣∣∣(v2r + )(β1r ± )(µr ± ) − v2rβ1rµr∣∣∣∣∣ + ∣∣∣∣∣(v2r +
)(β¯r ± ) − v2r (β¯r ± )
∣∣∣∣∣
=
∣∣∣∣∣(µrβ1r ± v2rβ1r ± β1r ± µrv2r + v2r ± µr + 2)∣∣∣∣∣ + ∣∣∣∣∣(v2r ± v2r − β¯r + )∣∣∣∣∣ ≤ emax,
and
∣∣∣∣∣0.5[µ2(s2 + v2β21)− µ2r (s2 + v2β21)+ µ[−2v2β1β¯+ 2v2rβ1rβ¯r]+ (v2β¯2 − v2r β¯2r )+ log ( vspirvr sr )∣∣∣∣∣
≤
∣∣∣∣∣0.5(µ2(s2 + v2β21) − µ2r (s2 + v2β21))∣∣∣∣∣ + ∣∣∣∣∣µ(v2β21β¯ − v2rβrβ¯r)∣∣∣∣∣ + ∣∣∣∣∣0.5(v2β¯2 − v2r β¯2r )∣∣∣∣∣ + ∣∣∣∣∣ log ( vspirvrsr
)∣∣∣∣∣
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≤
∣∣∣∣∣0.5((µ2r + )(s2r + ) + (v2r + )(β21r + ) − µ2r s2r − µ2rv2rβ2r ))∣∣∣∣∣ + ∣∣∣∣∣(µr ± )((v2r + )(β21r + )(β¯r ± ) − v2rβrβ¯r)∣∣∣∣∣
+
∣∣∣∣∣0.5((v2r + )(β¯2r + ) − v2r β¯2r )∣∣∣∣∣ + ∣∣∣∣∣ log 1pir ∣∣∣∣∣ + ∣∣∣∣∣ log vr+vr ∣∣∣∣∣ + ∣∣∣∣∣ log sr+sr ∣∣∣∣∣
≤
∣∣∣∣∣(µ2r + s2r +  + v2rµ2r + µ2rβ21r + v2rβ21r + v2r + β21r + )∣∣∣∣∣ + ∣∣∣∣∣(v2r + β¯2r + )∣∣∣∣∣
+
∣∣∣∣∣(µrv2r β¯r ± β21rµrv2r ± µrv2r + µrβ21rβ¯r ± µrβ21rµrβ¯r ± 2µr ± v2rβ21rβ¯r + v2rβ21r ± v2r β¯r2v2r ± β21rβ¯r
+2β21r ± 2β¯r + 3
)∣∣∣∣∣
+
∣∣∣∣∣ log 1pir ∣∣∣∣∣ ± vr (1 + O()) + ± sr (1 + O()) = fmax,
Thus we have for x > 0 and y > 0 that
exp
(
− 0.5
[
ax2 + bx + cxy + dy2 + ey + f
])
∗ M()
∣∣∣∣∣ λ∑
j=0
t∑
r=0
xt−ryλ− j
∣∣∣∣∣
≤ exp
[
amax,x2 + bmax,x + cmax,xy + dmax,y2 + emax,y + fmax,
]
∗ M()
∣∣∣∣∣ λ∑
j=0
t∑
r=0
xt−ryλ− j
∣∣∣∣∣
The afore-derived expression is wholly in terms of x and y, the true parameters
and . Thus we may define H5(x, y) for the different values that x and y can assume
as follows:
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H5(x, y) =
∣∣∣∣∣D5 fγrpir fr ∣∣∣∣∣3 =
(
e[amaxx
2+bmaxx+cmaxxy+dmaxy2+emaxy+ fmax] ∗ M()
∣∣∣∣∣ ∑λj=0 ∑tr=0 xt−ryλ− j∣∣∣∣∣)3 x ≥ 0, y ≥ 0(
e[amaxx
2+bminx+cminxy+dmaxy2+emaxy+ fmax] ∗ M()
∣∣∣∣∣ ∑λj=0 ∑tr=0 xt−ryλ− j∣∣∣∣∣)3 x ≤ 0, y ≥ 0(
e[amaxx
2+bmaxx+cminxy+dmaxy2+eminy+ fmax] ∗ M()
∣∣∣∣∣ ∑λj=0 ∑tr=0 xt−ryλ− j∣∣∣∣∣)3 x ≥ 0, y ≤ 0(
e[amaxx
2+bminx+cmaxxy+dmaxy2+eminy+ fmax] ∗ M()
∣∣∣∣∣ ∑λj=0 ∑tr=0 xt−ryλ− j∣∣∣∣∣)3 x ≤ 0, y ≤ 0
Now we show that E(H5(X,Y)) < ∞ as follows:
E(H5(X,Y)) =
∫ ∞
−∞
∫ ∞
−∞ H5(x, y) f0dxdy =
∫ ∞
−∞
∫ ∞
−∞ pi1H5(x, y) f1dxdy+
∫ ∞
−∞
∫ ∞
−∞ pi2H5(x, y) f2dxdy . . .+∫ ∞
−∞
∫ ∞
−∞ piqH5(x, y) fqdxdy
However by appealing to the linearity of the integration above we have for the
first part that:
∫ ∞
−∞
∫ ∞
−∞ pi1H5(x, y) f1dxdy < ∞ since E(Xp) < ∞, E(Y p) < ∞ and E(Xt−rYλ− j) < ∞
and the exponential functions H5(x, y) f1 ∝ ¯¯f1 which resembles Gaussian densities and
thus the kernel method is applicable. Moreover since these facts hold for each of the
q integrations above we conclude that E(H5(X,Y)) < ∞ which concludes the proof of
P0.
To prove P1 we appeal to Yakowitz’s and Spragins’ (1968)[61] characterizations
of identifiability theorem that a finite mixture from a family F of cdf’s is identifi-
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able iff F is linearly independent over the real numbers. Since the identifiability has
been checked by Yakowitz’s and Spragins’ (1968)[61] proposition 2, the proof of P1
follows forthwith as shown below noting yet again that f0 is the q mixture at the null.
Lemma 1. Suppose that
m1∑
i=1
γi f (x, y, θi) =
m2∑
i=1
αi f (x, y,Φi)
then we see that taking integrals on both sides yield
∫ r
−∞
∫ s
−∞
m1∑
i=1
γi f (x, y, θi)dxdy =
∫ r
−∞
∫ s
−∞
m2∑
i=1
αi f (x, y,Φi)dxdy
⇐⇒
m1∑
i=1
∫ r
−∞
∫ s
−∞
γi f (x, y, θi)dxdy =
m2∑
i=1
∫ r
−∞
∫ s
−∞
αi f (x, y,Φi)dxdy
⇐⇒
m1∑
i=1
γiF(r, s, θi) =
m2∑
i=1
αiF(r, s,Φi),
which is identifiable according to proposition 2 in Yakowitz and Spragins[61]. We
conclude that identifiability of a family of Gaussian cdf’s implies identifiability of the
corresponding pdf’s. This means that m1 = m2, γi = αi, and θi = Φi for all 1 ≤ i ≤ m1.
Lemma 2. Suppose that α1 f1(x, y, θ1) + . . . + αk fk(x, y, θk) =
∑k
l=1 αl fl(x, y, θl) = 0,
then we have by integrating both sides that∫ u
−∞
∫ v
−∞
k∑
l=1
αl fl(x, y, θl)dxdy = 0⇐⇒
k∑
l=1
∫ u
−∞
∫ v
−∞
αl fl(x, y, θl)dxdy = 0⇐⇒
k∑
l=1
αlFl(u, v, θl) = 0,
which implies that α1 = . . . αk = 0 by Yakowitz and Spragins [61]. Thus linear
independence of a family of Gaussian cdf’s implies the linear independence of the
corresponding pdf’s.
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Define f¯ (x, y, γ, γ0) =
{(
f
γl
f0
)
l=1,...,p
,
(
f
γl0
f0
)
l=1,...,q
,
(
D1i fγl0
f0
)
l=1,..,q,i=1,..,k
,
(
D2i j fγl0
f0
)
l=σ(1),..,σ(p2),i, j=1,...,k
}
={(
fγ1
f0
,
f
γl
f0
, . . . ,
fγp
f0
)
,
(
fγ10
f0
,
fγ20
f0
, . . . ,
f
γq0
f0
)
,
(
D1i fγ10
f0
,
D1i fγ20
f0
, . . . ,
D1i fγq0
f0
)
i=1,..,k
,
(
D2i j fγ10
f0
,
D2i j fγ20
f0
, . . . ,
D2i j fγσ(p2)0
f0
)
l=σ(1),..,σ(p2),i, j=1,...,k
}
according to the notations in [55].
Suppose for some constants η1l, . . . , η4b we have that
p∑
l=1
η1l
( fγl
f0
)
+
q∑
a=1
η2a
( fγa0
f0
)
+
q∑
a=1
η3a
(D1i fγa0
f0
)
i=1,..,k
+
σ(p2)∑
b=σ(1)
η4b
(D2i j fγb0
f0
)
i, j=1,...,k
= 0. (3.26)
Recall from Lemma 1 and 2 that
∑p
l=1 η1l
(
f
γl
f0
)
= 0 ⇐⇒ ∑pl=1 η1l f ∗ = 0 implies that
η11, . . . , η1q = 0 and similarly,
∑q
a=1 η2a
(
fγa0
f0
)
= 0 ⇐⇒ ∑qa=1 η2a f ∗γa0 = 0 implies that
η21, . . . , η2q = 0. Recall again that the partial derivatives of the density results in a
product of a polynomial (as described in equation 3.25) and the density. Moreover,
the polynomial is continuous on a compact set of parameters and thus bounded by
some M() for  ∈ (0, 1). As a result we note from f¯ (x, y, γ, γ0) suppressing all other
indices that:
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p1∑
l=1
η1l
fγl
f0
+
q∑
a=1
η2a
fγa0
f0
+
q∑
a=1
η3a
D1 fγa0
f0
+
σp2∑
b=σ(1)
η4b
fγb0
f0
=
p1∑
l=1
η1l f ∗γl+
q∑
a=1
η2a f ∗γa0+
q∑
a=1
η3a
λ∑
j=0
t1∑
r=0
cr1(γ)x
t1−r1yλ1− j f ∗
γa0
+
σp2∑
b=σ(1)
η4b
λ∑
j=0
t∑
r=0
cr(γ)xt−ryλ− j f ∗γb0
≤
p1∑
l=1
η1l f ∗γl+
q∑
a=1
η2a f ∗γa0+
q∑
a=1
η3a
λ∑
j=0
t1∑
r=0
M1()xt1−r1yλ1− j f ∗γa0+
σp2∑
b=σ(1)
η4b
λ∑
j=0
t∑
r=0
M()xt−ryλ− j f ∗
γb0
=
p1∑
l=1
η1l f ∗γl +
q∑
a=1
η2a f ∗γa0 +
q∑
a=1
η∗3a f
∗
γa0
+
σp2∑
b=σ(1)
η∗4b f
∗
γb0
= η11 f ∗γ1+. . .+η1p f
∗
γp1 +η21 f
∗
γ10
+. . .+η2q f ∗γq0+η
∗
31 f
∗
γ10
+. . .+η∗3q f
∗
γq0
+η∗41 f
∗
γ10+. . .+η
∗
4σ(p2) f
∗
γσ(p2)
= η11 f ∗γ1 + . . . + η1p f
∗
γp1 + (η21 + η31 + η41) f
∗
γ10
+ . . . + (η2q + η3q + η4q) f ∗γq0 + η4σ(p2) f
∗
γσ(p2)
= e1 f1 + . . . er fr,
where η∗4b = η4b
∑λ
j=0
∑t
r=0 M()x
t−ryλ− j, η∗3a = η3a
∑λ
j=0
∑t1
r=0 M1()x
t1−r1yλ1− j, e1 = η11,
er = η4σ(p2), f1 = f
∗
γ1
and fr = f ∗γσ(p2) .
Suppose now that e1 f1 + . . . er fr = 0 then by virtue of Lemma 1 and 2, e1 = . . . er = 0
since η11, . . . , η4σ(p2) = 0 by identifiability and illustrations above. Thus making the
set of functions in f¯ (x, y, γ, γ0) linearly independent which establishes P1 as required.
Assuming P0 and P1 we invoke theorem 3.2 in [55] as follows by first recalling
that Tn(k) = sup
g∈Gk
ln (g) − ln ( f0) and noting that:
Tn(k)
d→ 1
2
sup
d∈D
ξ2d1ξd≥0
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and
Tn(q)
d→ 1
2
sup
d0∈D0
ξ2d01ξd0≥0,
where D is the subset of the unit sphere of H (Hilbert space) of functions of the
form 1N(θ)
(∑q
l=1 pi
0
l
∑k
i=1 δ
l
i
D1i fγl,0
f0
+
∑p−q
i=1 λi
fγi
f0
+
∑q
l=1 ρl
f
γl,0
f0
)
and ξd is the Gaussian process
indexed by D as defined in [55].
So following from theorem 3.6 in [55] we have that:
Vn = sup
g∈Gk
ln
g
f0
− sup
g∈Gq
ln
g
f0
= ln
sup
g∈Gk
g
f0
sup
g∈Gq
g
f0
d→ 1
2
sup
µ∈U
ξ2µ1ξµ≥0
It follows from above that Vn = Op(1), which gives us assumption A1 in Drton
and Plummer (2016).
Now we show that A2 in Drton and Plummer (2016) is also satisfied by the mix-
ture of regression model. We begin by adopting the simplistic forms g = g(xi, yi) and
f = f (xi, yi) respectively unless otherwise defined.
We further define the following three models; the first two are considered true models
and the last, false model:
Tn(k) = sup
g∈Gk
∑n
i=1 ln (g) −
∑n
i=1 ln ( f0), Tn(q) = sup
g∈Gq
∑n
i=1 ln (g) −
∑n
i=1 ln ( f0)
Tn(p) = sup
g∈Gp
∑n
i=1 ln (g) −
∑n
i=1 ln ( f0).
We notice from above that Tn(k) − Tn(q) = Op(1). In the same spirit of LRT and
following the approach adopted in [45] we may state the comparison between a false
model Tn(p) and a true model Tn(k) as follows:
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Tn(p) − Tn(k) = Tn(p) − Tn(q) + Tn(q) − Tn(k) = Tn(p) − Tn(q) − Op(1). (3.27)
We also note by the strong law of large numbers that:
1
n
∑n
i=1 ln (g)
a.s→ E(ln(g)) and
1
n
∑n
i=1 ln ( f )
a.s→ E(ln( f )), under the assumption that pˆi a.s→ pi, θˆ a.s→ θ and Kˆ a.s→ K
(and the parameters spaces are compact). It follows by Slut sky’s theorem that:
1
nTn(p) − 1nTn(q) − 1nOp(1)
a.s→ sup
g∈Gp
E
(
ln gf
)
− sup
g∈Gq
E
(
ln gf
)
= sup
g∈Gp
E
(
ln(g)
)
− sup
g∈Gq
E
(
ln(g)
)
.
Recalling from equation 3.28 above we have that:
1
nTn(p) − 1nTn(k)
a.s→ sup
g∈Gp
E
(
ln(g)
)
− sup
g∈Gq
E
(
ln(g)
)
≤ −
[
inf
g∈Gp
(
− ln
(
E(g)
))
+ sup
g∈Gq
ln
(
E(g)
)]
= −∆, by Jensen’s inequality where ∆ > 0 and
p < q.
Thus we conclude that
P
(
1
nTn(p) − 1nTn(q) ≤ −∆2
)
→ 1 for n→ ∞, and so
Tn(p) − Tn(q) = sup
g∈Gp
∑n
i=1 ln(g) − sup
g∈Gq
∑n
i=1 ln(g) = ln
sup
g∈Gp
∏n
i=1 g
sup
g∈Gq
∏n
i=1 g
≤ −n∆2 . It follows that
sup
g∈Gp
∏n
i=1 g
sup
g∈Gq
∏n
i=1 g
≤ exp{−n ∆2 }
which is akin to A2 in Drton and Plummer 2016.
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Finally A3 in Drton and Plummer 2016 follows immediately from [44] and [45]
by recalling that the learning coefficient pertaining to the mixture of regression as
discussed earlier is bounded as follows: λi j ≤ 12 [6i+ j−1] ∀ j < i. We assumed that the
multiplicity mi j = ml = meek = 1 for some i, j, k, l ∈ I. Denote the lexicographic order
on R2 by ≺ and note that for any model indexed by j, k ∈ I and sub models indexed by
i, l ∈ I for all i < j < k and l < i < j we can easily check that (λi j,−mi j) ≺ (λeek,−meek)
and likewise (λl,−ml) ≺ (λi j,−mi j). For instance for any model with indices j = 3, k =
4 ∈ I and sub models with indices l = 1, i = 2 ∈ I, it is obvious that (λ32,−1) ≺
(λ42,−1) ⇐⇒ (18/2,−1) ≺ (25/2,−1) and similarly (λ31,−1) ≺ (λ32,−1) ⇐⇒ (9,−1) ≺
(19/2,−1) respectively.
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Chapter 4 A Singular Flexible Information Criterion From A Mixture of
Linear Regressions Perspective
4.1 Introduction
In this chapter we will establish a novel model selection criterion for mixture of re-
gression models called the SFLIC (Singular Flexible Information Criterion). In the
more basic setting of an ordinary mixture, SFLIC is a hybrid between FLIC[27] and
sBIC [44]. The SFLIC developed in this work is methodologically different from that
in [45], in that the modeling framework here is a mixture of regression model contrary
to that of [45] which is a heirarchical mixture model setting, making the derivation
approaches very different. The following steps will be traversed to fully develop this
new criterion.
1. First we will identify a penalty that will increase or decrease depending on
whether there is apparent homogeneity or heterogeneity in the mixture problem
at hand. The chosen penalty will also possess the ability to sandwich the
criterion between some singular versions of AIC and BIC (sAIC and sBIC if
you will); so that when the criterion is very liberal it will bear the mark of
sAIC and when it is very conservative it will resemble the sBIC. We may define
the sAIC as the AIC for a singular model (i.e. AIC with a learning coefficient
instead of the number of parameters). In other words sAIC may be defined as
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2∗ loglik−2∗λ and sBIC may be defined as 2∗ loglik−2∗λ∗ log(n). Both sAIC
and sBIC, although slightly different from AIC and BIC, account for singularity
of the model.
2. Secondly, we will adapt Pilla and Charnigo’s(2007) bivariate function for a
vector outcome (contrary to the scalar outcome in Pilla and Charnigo(2007)).
This function was chosen because as part of the penalty, it will exhibit the
characteristics described above.
3. Thirdly, since our goal is to create a criterion that works in the general settings
work as described by Drton and Plummer(2016), we will adopt that general
setting but replace the penalty in Drton and Plummer (2016) with the penalty
established here and call it SFLIC. Importantly Drton and Plummer(2016) did
not consider specifically a mixture regression model.
4. Fourthly, we examine the statistical properties of the new criterion in regards
to determine if it converges in probability to the correct order. That is, does
mˆ := argmaxm∈{1,2,..,M}S FLICm
p→ m0 where m0 is the true order of the model?
4.2 Deduction of Within and Between Covariance Matrices
To address objective one regarding penalty formulation, we will appeal to the under-
lying concept of ANOVA and compare component specific fitted models to component
specific outcomes on one hand; and on the other, compare the component specific
fitted models to a weighted model fitted to all the components. The former com-
parison will be the within variance covariance structure and the latter, the between
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variance covariance structure.
Within Variance Covariance Matrix Derivation
By definition the residual of a fitted regression model is the difference between
the observed and the predicted outcomes. For the purposes of our mixture re-
gression problem we more explicitly represent the residual for rtaubeta on race as:
êi1 j = Yi1 j− (β̂01 j + β̂11 jXi) conditional on being in component j and similarly represent
the residual resulting for rptaubeta on race as êi2 j = Yi2 j − (β̂02 j + β̂12 jXi). (This can
be generalized to multiple covariates.)
In essence êi1 j will measure the distance from Yi1 j to Ŷi1 j if we know that subject
i is in component j, where i = 1, 2, ..., n and j = 1, 2, ..,m, m being the number tem-
porarily assumed known mixture components in the model. Thus i1 j will correspond
to the ith observation for outcome one (in this case rtaubeta) if assumed in the jth
mixture component.
Using the definition above for residuals we can estimate the hard and soft classifi-
cation aggregated within variances (similar to generalized variance in a multivariate
setting) as follows:
Hard Classification
Whm :=
m∑
j=1
 n∑
i
1i jê2i1 j
n∑
i
1i jê2i2 j −
 n∑
i
1i jêi1 jêi2 j
2
 (4.1)
where 1i j = 1P̂i j=max1≤k≤m P̂eek . In words, the indicated condition says that for person
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i, the conditional probability of belonging to component j is greater than or equal
to the conditional probability of belonging to component k for any k. Whm is the
summation of component specific determinants.
Soft Classification
Wsm :=
m∑
j=1
 n∑
i
P̂i jê2i1 j
n∑
i
P̂i jê2i2 j −
 n∑
i
P̂i jêi1 jêi2 j
2
 (4.2)
where P̂i j is the posterior probability of individual i belonging to component j given
all the information we know about this individual.
Between Variance Covariance Matrix Derivation
Here we aim to examine the variation between each component’s fitted model
and the weighted average of all the models fitted to the various components. This
will quantify how different the model fitted to a given component compares to the
weighted average of the rest. We begin by drawing analogy to one way ANOVA and
define the subject specific contribution to between variance in the context of mixture
of linear regressions as follows:
The between variance resulting from assignment of subject i to component j re-
garding rtaubeta is:
B̂2i1 j :=
(β̂01 j + β̂11 jXi) − m∑
l
pil(β̂01l + β̂11lXi)
2 (4.3)
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where pil is the proportion of membership in component l and the between variance
from rptaubeta is
B̂2i2 j :=
(β̂02 j + β̂12 jXi) − m∑
l
pil(β̂02l + β̂12lXi)
2 (4.4)
where m is the number of components.
Verbally we may interpret B̂i1 j as the distance from Ŷi1 j knowing that subject i is in
component j from Ŷi1. if we don’t know to which component subject i belongs, where
Ŷi1. =
∑m
l pil(β̂02l + β̂12lXi).
The corresponding hard and soft classification summation of component specific
determinants are as follows:
Hard Classification
Bhm :=
m∑
j=1
 n∑
i
1i jB̂2i1 j
n∑
i
1i jB̂2i2 j −
 n∑
i
1i jB̂i1 jB̂i2 j
2
 (4.5)
Soft Classification
Bsm :=
m∑
j=1
 n∑
i
P̂i jB̂2i1 j
n∑
i
P̂i jB̂2i2 j −
 n∑
i
P̂i jB̂i1 jB̂i2 j
2
 , (4.6)
where P̂i j is as previously defined.
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4.3 Definition and Derivation of SFLIC
Having established aggregated within and between variances for the mixture of linear
regression model, we proceed to define a statistic that will be used to later describe
the degree of heterogeneity in the fitted mixture models.
Define
τ(Y) :=
1
M
M∑
k=1
Wk(Y)
Bk(Y) + Wk(Y)
(4.7)
where Wk(Y) is either Wkh(Y) or Wks(Y) and likewise for Bk(Y).
We are thus averaging WkBk+Wk ratio over all models under consideration. It follows
that large(small) values of τ(Y) may be indicative of more homogeneity(heterogeneity)
in the data.
According to Pilla and Charnigo (2007) we can define a bivariate function such
that:
B(n, τ(Y)) =
Φ((log (
√
n)τ(Y))) − Φ(1)
1 − Φ(1) (4.8)
Using the bivariate function above we define the singular flexible information cri-
terion (SFLIC) as follows inspired by Drton(2016):
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S FLICk := 2 log P[Yn|pi0,Mk] − 2λk(pi0) log (n)B(n,τ(Y)) (4.9)
also assuming a multiplicity factor of 1 as in Drton (2016) and Fan(2014) where
the terms in 4.11 are similar to those defined in chapter two under ’Review of related
concepts’.
We deduce the following observations from the SFLIC:
1) If n→ ∞ then B(n, τ(Y)) a.s→ 1 because as n→ ∞
B(n, τ(Y)) =
Φ((log (
√
n)τ(Y))) − Φ(1)
1 − Φ(1) ≥
Φ((log (
√
n)
1
M )) − Φ(1)
1 − Φ(1)
a.s→ 1
and so SFLIC becomes
S FLICk = 2 log P[Yn|pi0,Mk] − 2λk(pi0) log (n)
which is akin to sBIC.
2) If τ(Y) is small then B(n, τ(Y)) ≈ 0 because
Φ((log (
√
n)τ(Y))) ≈ Φ(1) =⇒ Φ(1) − Φ(1)
1 − Φ(1) = 0
. Thus SFLIC will be approximately
S FLICk = 2 log P[Yn|pi0,Mk] − 2λk(pi0),
which is akin to sAIC or how the AIC might be defined for a singular model.
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Thus the SFLIC is sandwiched between sBIC and sAIC and drifts to the former
as n tends to infinity.
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4.4 Consistency of SFLIC
In a similar analogy to Drton (2016) we consider a finite set of true models Mi : i ∈ I
and a fixed data generating distribution pi0 ∈ ⋃i∈IMi . Mi is true if pii ∈ Mi else Mi is
false. A smallest true model Mi is a true model whose sub models are all false model.
That is if j ≺ i⇒ pi0 < M j.
Mi is said to have a smaller Bayes complexity than M j if (−λi(pi0),Mi(pi0)) < (−λ j(pi0),M j(pi0))
for pi0 ∈ Mi. This is equivalent to λi(pi0) > λ j(pi0). Of note the Bayes factor is de-
fined as nλi(pi0)(log n)mi(pi0)−1 where λi(pi0) is the learning coefficient and mi(pi0) is its
corresponding multiplier. The former and latter together describes the complexity
of model Mi under the data-generating distribution pi0.
The following assumptions have been shown to be consistent with the proposed
mixture of regression models.
Assumptions proposed by Drton (2016)
A1) for any two true models Mi and M j
P(Yn|pˆik,Mk)
P(Yn|pˆii,Mi) = Op(1)
A2) For any pair of a true model Mi and false model Mk ∃ a constant δeek > 0
such that
P(Yn|pˆik,Mk)
P(Yn|pˆii,Mi) ≤ e
−δeekn
as n→ ∞
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A3) Let Mi and Mk be any two true models such that j  i and l  k index any
two respective sub models. Then the Bayes complexity is monotonically increasing
in the sense (−λi j,mi j) < (−λi j,mkl) if i ≺ k and j  l.
Theorem 4.1 (Consistency): Ler Mi be the model selected by maximizing the
SFLIC, that is
iˆ = argmaxi∈IS FLIC(Mi). (4.10)
Then under assumptions A1-A3, the probability that Mi is a true model of minimal
Bayes complexity and thus the smallest true model tends to one as n goes to infinity.
it suffices to show that:
1. The SFLIC of any true model is asymptotically larger than that of any false
model.
2. SFLIC of a true model can be asymptotically maximal only if the model mini-
mizes Bayes complexity among the true models.
Proposition 4.1
Under assumption (A2) above, if model M′i is true and model M
′
k is false then the
probability that
S FLIC(M′i ) > S FLIC(M
′
k)→ 1, n→ ∞ (4.11)
To show prove proposition 4.1 we fix j′  i′ and l′  k′ and let M′k and M′i be
respectively false and true models. Then according to assumption A2 in Drton(2016)
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we have that
P(Yn|pˆi′k,M′k)
P(Yn|pˆi′i ,M′i )
< e−δi′k′n .
Thus there exist  > 0 such that
P
[∣∣∣∣∣∣P(Yn|pˆi′k,M′k)P(Yn|pˆi′i ,M′i ) − e−δi′k′n
∣∣∣∣∣∣
]
→ 0, n→ ∞ (4.12)
Hence following the definition of consistency we have that
P(|S FLICk − S FLICi|< )
= P(|P(Yn|pˆi′k,M′k) − P(Yn|pˆi′i ,M′i ) − log(n)B(n,τ(y))(λk(pi0) − λi(pi0))|< )
≤ P(|P(Yn|pˆi′k,M′k) − P(Yn|pˆi′i ,M′i )|< /2) + P(|log(n)B(n,τ(y))(λk(pi0) − λi(pi0)|< /2)
But
P(|log(n)B(n,τ(y))(λk(pi0) − λi(pi0)|< /2) = P
(∣∣∣log(n)B(n,τ(y))∣∣∣ < /2
λk(pi0) − λi(pi0)
)
→ 0, n→ ∞
(4.13)
and
P(|P(Yn|pˆi′k,M′k) − P(Yn|pˆi′i ,M′i )|/2) = P(|Op(P(Yn|pˆi′i ,M′i )) − P(Yn|pˆi′i ,M′i )|< /2)
= P(|P(Yn|pˆi′i ,M′i )(Op(1) − 1)|< /2) = P
(
|P(Yn|pˆi′i ,M′i )|<
/2
(Op(1) − 1)
)
→ 0, n→ ∞
(4.14)
As a result
P(|S FLICk − S FLICi|< )→ 0, n→ ∞ (4.15)
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4.5 Application of SFLIC to the ADNI data
The SFLIC was applied to the ADNI data, specifically to the mixture of regression
model with race as covariate. The SFLIC favored a 2 component (S FLIC ≈ 746.8)
mixture model slightly over a three component (S FLIC ≈ 743.5) and in the apoe4
mixture model, SFLIC selected two components (S FLIC ≈ 747.5) as opposed to three
components (S FLIC ≈ 744.6). When the SFLIC was applied to the race and apoe4
mixture of regression model, it once again favored a two component (S FLIC ≈ 746.5)
to a three component (S FLIC ≈ 743.4). Thus in all three models SFLIC (similar to
SBIC considering the model with more stable standard errors) selected the number
of components that produced stable standard errors as seen in chapter 3.
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Chapter 5 Simulation Studies
5.1 Introduction
Mixture modeling applications have been well received in many fields for identifying
subgroups underlying a given population in a non-parametric manner. For instance
mixture modeling has been applied in market response models and multidimensional
scaling Sarstedt and Schaiger(2008). Andrews and colleagues (2002) also identified
finite mixture modeling as a comparable model to the well received hierarchical Bayes
conjoint analysis models in terms of model fit, prediction and robustness with regards
to individuals decision making in market research. Crawford et. al(2012) recently ap-
plied mixture models to classify lake chemistry distributions into lake sub population.
5.2 Overview of Approach
The foregone background suggests that indeed mixture modeling is widely used as
a tool in many fields to address varied problems and to make important decisions.
But to be able to make a well informed decisions based on this modeling approach,
it is imperative for one to identify the correct number of heterogeneity underlying
the population on interest. To this end, and as we have already elaborated in the
previous chapters, AIC and BIC are popular in this regard. Drton and colleagues
(2016) have also added sBIC which is both suitable for modeling in the presence of
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identifiability issues and tends to be less extreme in comparison to AIC and BIC.
Furthermore, SFLIC was developed specifically to be able to address model selection
problems in mixture of regressions in the presence of identifiability issues. However
no study to the best of our knowledge has compared the performance of these four
criteria in regards to their ability to correctly identify the heterogeneity in the data.
The importance of a correct identification of the different segments underlying the
population from which the data are obtained, is invaluable to reach reasonable deci-
sions from any analysis (Sarstedt et. al (2008).
As a result, the purpose of this chapter is to conduct simulation study to compare
the performance of the novel model selection criterion developed in chapter four to
AIC, BIC and SBIC. In our quest we will further compare the performance of each
of the criteria to random chance, proportional chance and maximum chance criteria
as suggested by Sarstedt and Schaiger(2008). In particular our study will seek to
address the following goals:
1. For a known number of mixing component in a mixture of regression model
how well does SFLIC perform in comparison to AIC, BIC and sBIC.
2. For varying sample sizes and known number of mixing component in a mixture
of regression model how well does SFLIC perform in comparison to AIC, BIC
and sBIC.
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5.3 Simulation Design and Results
Three simulations were conducted namely; the race mixture of regression model
simulation, the Apoe4 mixture of regression model simulations and the race and
Apoe4 mixture model simulations. Each simulations followed the steps outlined
below:
1. The covariates were drawn from Bernoulli distribution with a prespecified prob-
ability of 0.9 for race and 0.27 for Apoe4. These probabilities were determined
from the original data.
2. The biomarker ratios were also drawn from two component normal mixture of
regression.
3. FlexMix package[41] in R was utilized to obtain a finite mixture of regression
with one or two covariates depending on the model. The number of components
k was varied from 2 to 4 and SFLIC, AIC, BIC and sBIC were used to select
the correct number of components which are called their success rates.
4. The simulation exercise was repeated for 7 sample sizes from 500 to 5000 in an
uneven increment and 8000.
5. The performances of the model selection criteria were displayed in a success rate
by sample size graph. The simulation size was fixed at B = 50. This simulation
size was chosen to make the process less expensive regarding computational
memory.
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Simulation Results: race mixture model
The results of the race mixture model simulation shows the following:
1. All the model selection criteria performed better than the random chance cri-
terion (0.33) and the proportional chance (0.32 + 0.32 + 0.42 = 0.34).
2. Overall BIC was sub optimal in comparison.
3. SFLIC and AIC performed slightly better than sBIC.
4. For sample sizes less than or equal to 4000 but greater than 2000, AIC and
SFLIC performed about the same.
5. For sample sizes below 3000 SFLIC performed the slightly better than sBIC
and AIC.
6. For sample larger than 4000, AIC performed slightly better than SFLIC.
Simulation Results: Apoe4 mixture model
The results of the Apoe4 mixture model simulation shows the following:
1. All the model selection criteria performed better than the random chance cri-
terion (0.33) and the proportional chance (0.32 + 0.32 + 0.42 = 0.34).
2. Overall BIC was sub optimal in comparison.
3. Overall SFLIC and AIC performed slightly better than sBIC.
4. For sample sizes from 2000 to 4500, the SFLIC performed and AIC performed
about the same.
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5. For sample larger than 4500, AIC performed slightly better than SFLIC.
Simulation Results: race and Apoe4 mixture model
The results of the race and Apoe4 mixture model simulation shows the following:
1. All the model selection criteria performed better than the random chance cri-
terion (0.33) and the proportional chance (0.32 + 0.32 + 0.42 = 0.34).
2. Overall BIC was sub optimal in comparison.
3. Overall SFLIC and AIC performed slightly better than sBIC for smaller sample
sizes.
4. For sample sizes between to 2000 and 2500 SFLIC performed slightly better
than AIC.
5. For sample sizes above 2500 SFLIC performed the slightly better than sBIC
and AIC.
6. For sample larger than 2500, SFLIC, AIC and sBIC all performed about the
same.
7. All four criteria had a success rate at or better than 37% and they all seem to
perform compartively better in the race only simulations.
8. None of the criteria achieved 100% success rate partly because the sample
size increases, the penalty grows logarithmically (refer to chapter 4) and thus
SFLIC and SBIC become very conservative behaving more like BIC.
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Figure 5.1: Simulation comparing the success rates of SFLIC, AIC, BIC and SBIC
with respect to the race mixture of regression model. Here the true mixture is k=2
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Figure 5.2: Simulation comparing the success rates of SFLIC, AIC, BIC and SBIC
with respect to the apoe4 mixture of regression model. Here the true mixture is k=2
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Figure 5.3: Simulation comparing the success rates of SFLIC, AIC, BIC and SBIC
with respect to the race and apoe4 mixture of regression model. Here the true
mixture is k=2
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Chapter 6 Supplementary Chapter
6.1 Introduction
This section addresses models that were fitted that were comparable to those dis-
cussed in this work however fell short on some key elements. Below we addressed
each model and provide substantive reasons for their exclusion in the main work.
6.2 Review of Other Comparable Models Fitted As Part of This Work
1. The use of the raw CSF biomarkers have been used by De Meyer and colleagues
(2010) to predict AD. They also used Abeta/Ptau ratio. The difference however
lies in their objective, which was to identify AD patterns in an independent,
and unsupervised way. This also influenced the data they used.
2. When we fitted Abeta and ptau, AIC and sBIC choose three components model
against a four component model selected by BIC. When the grouping probabili-
ties were fitted in the Cox reg model we obtained an unadjusted c− stats = 66%
and adjusted c = 69.5% (results not shown). In this case the unadjusted c-
statistic is the c-statistic resulting from fitting the Cox model with only the
grouping probabilities. Adjusting the Cox model for covariates results in the
adjusted c-statistic. So comparatively, this model is sub optimal to the one
created with the ratios in terms of the c-statistic. We noted also that just
as in the ratio model, this model predicts being of white race as protective
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with a reduced risk of transitioning. Also the posterior plots indicated lots
of misclassifications in the model. In addition the medium risk was no longer
significant after accounting for other risk factors. This suggests that the pos-
terior probabilities from the raw biomarker model may not possess the same
predictive abilities as that of the ratios. Indeed it is possible that account-
ing for an appropriate risk could wipe the effect of the grouping probabilities
entirely. If this were the case, then mixture modeling apporach may not be
worthwhile, however, the identified appropriate risk factors will serve the in-
terest of the clinician whose key interest is to provide cure without endulging
in complicated metholodolgies such as mixture modeling.
3. Putting all three biomarkers in the model resulted in a c-statistic of 58.4%
(unadjusted) and 69.4% (adjusted) for the hard classification model (adjusted
67.5%) and (unadjusted 62.4%) for the soft classification model. When we
adjusted both hard and soft classification model for RAVLT, the c-statistics
were respectively 71% and 72% (results not shown). The estimated group
probabilities also had larger standard errors, which resulted in wider confidence
intervals. Again this model is sub optimal in comparison to the ratio model.
The group probability failed the proportional hazard test in the presence of the
other risk factors.
4. We conclude that the raw biomarkers may not possess the optimal grouping
probabilities needed for predicting future cognitive status of people who are
cognitively intact.
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5. Using pca was not helpful in predicting either. In addition pca loses meaning
due to the fact that it is a linear combination of the predictors (in this case the
biomarkers) and we’re not sure what the linear combination of the biomarkers
really means.
6. The ratio biomarkers are enhanced to identify risks in the sense that if we
keep the numerators tau and ptau fixed and reduce the denominator abeta,
then the entire fraction will be enhanced and thus provide an indicator of high
risk of transitioning. On the other hand, using just the raw biomarkers may
not be enhanced enough to capture the potential transitioning. In essence the
ratio is accounting for the effect of abeta indirectly and incorporating it in the
modeling procedures.
7. Also the use of ratios affords us the flexibility of having two derived quantities
that move in the same direction in terms of low , medium or high risks. That
is the ratios if low then low risk and if high then high risk is preferred to an
inverse one in using something like abeta and tau or abeta and ptau.
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